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Abstract 
Systems Metabolic Engineering of Microbial Cell Factories for the  
Synthesis of Value-added Chemicals  
by 
Arul Mozhy Varman 
Doctor of Philosophy in Energy, Environmental, and Chemical Engineering 
Washington University in St. Louis, 2013 
Professor Yinjie J. Tang, Chair 
 
Microbial cell factories offer us an excellent opportunity for the conversion of many 
different cheaply available raw materials into valuable chemicals. Systems metabolic 
engineering aims at developing rational strategies for the engineering of microbial hosts by 
providing global level information of a cell. This dissertation focuses on metabolic engineering, 
bioprocess modeling and pathway analysis, to develop robust microbial cell factories for the 
synthesis of value-added chemicals. The following research tasks were completed in this regard. 
First, statistical models were developed for the prediction of product yields in engineered 
microbial cell factories - Saccharomyces cerevisiae and Escherichia coli (Chapter 2). A large 
space of experimental data for chemical production from recent references was collected and a 
statistics-based model was developed to calculate production yield. The input variables 
(numerical or categorical variables) for the model represented the number of enzymatic steps in 
the biosynthetic pathway of interest, metabolic modifications, cultivation modes, nutrition and 
oxygen availability.  In addition, the use of 13C-isotopomer analysis method was proposed for the 
accurate determination of product yields in engineered microbes under complex cultivation 
conditions (Chapter 3).   
xiv 
 
Second, metabolic engineering of the cyanobacterium, Synechocystis sp. PCC 6803 was 
performed for synthesizing isobutanol under phototrophic conditions (Chapter 4).  With the 
expression of the heterologous genes from the Ehrlich Pathway, by incorporating an in situ 
isobutanol harvesting system, and also by employing mixotrophic conditions, the engineered 
Synechocystis 6803 strain accumulated a maximum of ~300 mg/L of isobutanol in a 21 day 
culture. In addition, Synechocystis 6803 was engineered for the synthesis of D-lactic acid 
(Chapter 5), via overexpression of a novel D-lactate dehydrogenase (encoded by gldA101). The 
production of D-lactate was further improved by employing three strategies: (i) cofactor 
balancing, (ii) codon optimization, and (iii) process optimization. The engineered Synechocystis 
6803 produced 2.2 g/L D-lactate under photoautotrophic conditions with acetate, the highest 
reported lactate titer among all known cyanobacterial strains. 
Finally, an E. coli cell factory was engineered to study the fermentation kinetics for 
scaled-up isobutanol production (Chapter 6).  Through kinetic modeling (to describe the 
dynamics of biomass, products and glucose concentration) and isotopomer analysis, we have also 
offered metabolic insights into the performance trade-off between two engineered isobutanol 
producing E. coli strains (a high performance and a low performance strain). The kinetic model 
can also predict isobutanol production under different fermentation conditions. I and my 
colleagues have also demonstrated that E. coli cell factory can also be used for converting waste 
acetate into free fatty acids through metabolic engineering. In conclusion, the opportunities and 
commercial limitations with current biotechnology as well as the role of systems metabolic 
engineering for the development of high performance microbial cell factories were discussed 
(Chapter 7).     
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Chapter 1: Introduction to systems metabolic engineering of 
microbial cell factories 
1.1 Introduction 
Biomass-derived carbon and energy have been used by human society for a long time.  
This dependence was shifted to petroleum derived carbon and energy in recent times. A 2008 
census indicated that most of the energy utilized worldwide came from the burning of fossil fuels 
and it accounted for about 80% of the energy consumed1. The U.S. Energy Information 
Administration had projected a 49% increase in global energy demand from 2007 to 20352.  This 
dependence on fossil fuels cannot go on forever as oil reserves have started dwindling. 
Furthermore, the USEPA reports that the atmospheric CO2 concentrations has increased by up to 
35% since the industrial revolution in the 1700’s3, while CO2 produced from burning fossil fuels 
contributed to about 56.6% (2004 data) of the total greenhouse gas emissions3.  In consideration 
of the energy security and environmental concerns there is a growing need for the production of 
biofuels and petroleum-derived chemicals from renewable sources.   
For the production of chemicals from microbes to be economical, the target chemical 
must be produced at high yield, titer and productivity.  These traits are  difficult to be met by 
naturally occurring microbes4.  Henceforth, microbes must be engineered to achieve the desired 
traits.  With the advent of recombinant DNA technology, we now have the tools to redesign 
metabolic pathways for the production of chemicals from renewable materials. Technologies 
beyond simple genetic engineering are often required to achieve a desired phenotype and much 
of this rational modification has been performed in the form of metabolic engineering. Metabolic 
engineering is the improvement of cellular activities by manipulation of enzymatic, transport, 
2 
 
 
and regulatory functions of the cell by the application of recombinant DNA technology5.  On the 
other hand, systems biology Metabolic engineering can be integrated with systems analysis and 
modeling to  perform rational engineering of microbial hosts6. 
1.2 Microbial cell factories 
Microbial biocatalysts offer several advantages in producing small-molecule chemicals. 
Unlike conventional chemical syntheses which are heavily dependent on petroleum-derived 
substrates, microbes are able to use renewable materials to synthesize many commodity 
chemicals and fuels7.  Due to its scalability, microorganisms are also suitable platforms to 
synthesize pharmaceutical molecules. Among the many industrial microorganisms, Escherichia 
coli and Saccharomyces cerevisiae have long been the industrial workhorses preferred for 
metabolic engineering applications.  These two organisms have well-established genetic tools 
and have been explored to create industrial scale production of chemicals from microbes8. 
Developments in genetic tools have led to the ability to efficiently engineer E. coli as a 
biocatalyst for the production of a wide variety of chemicals, potential biofuels and 
pharmaceuticals9.  S. cerevisiae is typically known for its robustness in fermenting sugars into 
alcohol. It has also gained importance as a heterologous platform to synthesize many precursors 
of commodity chemicals and pharmaceuticals 7. 
Sugars (such as glucose, xylose starch, and sucrose) have been widely used for biofuel 
production, which can be obtained either from food crops (corn, sugarcane, sugar beet) or from 
biomass polymers (i.e., cellulose and hemicellulose). To reduce feedstock costs, a great deal of 
effort has been focused on the isolation, characterization and engineering of a handful of species 
(e.g., Clostridium thermocellum and Clostridium phytofermentans) that can utilize cheap 
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biomass for bioproduct synthesis (such as ethanol)8. Engineered Clostridium cellulolyticum has 
been shown to produce isobutanol directly from crystalline cellulose10. More recently, E. coli 
was engineered for the production of biodiesel directly from hemicelluloses, a plant derived 
biomass11.  Utilizing non-sugar-based substrates, such as glycerol, lactate, acetate, CO2, and 
syngas (CO, CO2 and H2), for the production of value added chemicals has been a trend in recent 
years (Figure 1.1).  
 
Figure 1.1:  Metabolic engineering pathways for biofuel production 
 
Ethanol is currently the most commercially successful biofuel and can be produced by 
yeast fermentations. Yeast efficiently converts sugar into ethanol and CO2 via glycolysis pathway 
and pyruvate decarboxylase / alcohol dehydrogenase. Biofuels with properties similar to those of 
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gasoline and diesel fuel are being synthesized by microorganisms (Figure 1.1). Several 
engineered biofuel pathways are being examined. For example, engineered Escherichia coli can 
use the keto acid pathway and the Ehrlich pathway to produce higher alcohols (such as 
isobutanol), while the mevalonate pathway in yeast can be extended to synthesize branched and 
cyclic hydrocarbons (the biofuels with lower freezing point and higher energy content).  
Table 1.1:  Commonly employed microbes for biofuel production 
Species Substrates Products  Features 
Saccharomyces 
cerevisiae  
Glucose, fructose, 
galactose, and 
others 
Alcohols Easy genetic 
manipulations, Crabtree 
effect 
Zymomonas 
mobilis 
Glucose, fructose, 
sucrose 
Ethanol High ethanol tolerance and 
yield 
Clostridium 
thermocellum 
Glucose, cellulose, 
cellobiose 
Ethanol  Growth at high 
temperature, mixed 
fermentation pathways 
Clostridium 
acetobutylicum 
Glucose, xylose Ethanol and 
butanol 
Acetone, ethanol, and 
butanol fermentation 
Escherichia coli Glucose, xylose, 
glycerol, and others 
Alcohols, diesels, 
and other biofuels 
Easy genetic 
manipulations, fast growth 
Cyanobacteria 
(e.g., Synechocystis 
6803) 
CO2 Alcohols, H2, fatty 
acids 
CO2 fixation 
Phanerochaete 
chrysosporium 
Glucose and lignin  cellulosicbiomass 
pretreatment 
Strong ability to degrade 
lignin 
Yarrowia lipolytica Glucose, acetate 
and fatty acids 
Lipids Oleaginous yeast that 
accumulates lipids 
Finally, microbial metabolisms for biofuel production are very different across the 
species. Saccharomyces cerevisiae and Escherichia coli are microbial cell factories that are 
widely used in biofuel industrial because the two model species ferment sugar efficiently and are 
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also amenable to genetic modification and bioprocess scale up. Other microbial species, such as 
cyanobacteria, are also promising hosts for biofuel production because they can convert sunlight 
and CO2 to biomass and products. The species diversity in metabolic features offers opportunity 
for synthesizing many different useful products from diverse carbon substrates. Table 1.1 shows 
several different microbial species that produce biofuels, either via the native biofuel pathway or 
via a metabolically engineered pathway.  
 
1.3 Tools for genetic engineering of microbial hosts  
 Overexpression of native or heterologous genes is often achieved through plasmid based 
expression systems. Plasmids are naked DNA molecules that are capable of replication within 
the host. Plasmids are commonly used to carry genetic materials and transfer them to the 
microbial host. The gene expression is mainly controlled at the transcript level, i.e., by tuning 
with the promoter.  The most widely used promoters are the lac and the hybrid promoters such as 
tac, tic and trc.  These promoters can be induced under the presence of isopropyl-β-D-
thiogalactopyranoside (IPTG).  However, there is also research being done for the use of 
constitutive promoters for gene expression.  Some of them rely on the use of natural promoters 
and others rely on random mutation of constitutive promoters.  One of the goals of synthetic 
biology is to manipulate protein expression at the translation level and this can be achieved by 
modulation of the ribosomal binding site. Riboregualtors have been developed to tune gene 
expression by RNA-RNA interactions. Another method by which gene targets can be 
overexpressed is through codon optimization4.   
Plasmid based expression systems often suffer from unstable genetic performance.  
Chromosomal integration of target genes along with the promoter can be utilized to avoid this 
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problem. Often, overexpression of many genes would be required to achieve a desired yield.  
Novel approaches have been developed to control the coordinated expression of each gene.  One 
such approach combines multiple genes into an operon under the control of a single promoter 
and the expression of each gene is controlled at posttranscriptional stage by tuning the intergenic 
regions.  This method was applied for the coordinated expression of three genes of the 
heterologous mevalonate pathway in E. coli and resulted in an increase of the mevalonate 
production by sevenfold 12.   
 Knockout of competing pathways can redirect the flux of carbon towards the product of 
interest.  Gene deletion is often achieved through homologous recombination and traditionally 
this is performed through plasmids containing a selectable marker flanked by DNA fragments of 
the target gene. Genes can be deleted in yeast by the use of a linear PCR fragment along with a 
short flanking region homologous to the target DNA.  Gene deletions can also be performed 
using bacteriophage, and they depend on the FLP-FRP recombination to remove the marker after 
gene deletion. This method leaves a 68bp FRT scar on the chromosome for each deletion 
performed. 
 
1.4 Cyanobacteria as a microbial cell factory 
Direct capture of CO2 for the synthesis of bioproducts is a more economical and 
environmental friendly approach that has received extensive studies recently. Cyanobacteria or 
blue-green algae are photoautotrophic prokaryotes and can fix CO2 in the presence of sunlight.   
The photosynthetic efficiency of cyanobacteria is much higher than that of higher plants (10 – 
20% in contrast to 0.5% in higher plants)1. The transformability of some cyanobacteria species 
coupled with the availability of sequenced genomes allows us to perform complex genetic 
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engineering13.  They generally have high growth rates as compared to green algae and plants.  
The diversity of metabolic capability in cyanobacteria lets them grow in highly saline 
environments as well as marginal lands and hence will not compete with land used for 
agriculture14.  Among all cyanobacterial species, Synechocystis sp. PCC 6803 (hereafter 
Synechocystis 6803) is one of the most extensively studied species since it was initially isolated 
from a freshwater lake in 1968. The entire genome, including four endogenous plasmids, was 
sequenced in 1996, and over 3000 genes have been annotated to date15, 16.  Synechocystis 6803 
demonstrates versatile carbon metabolisms, growing under photoautotrophic, mixotrophic and 
heterotrophic conditions 17. Additionally, biochemical similarities between the plant chloroplasts 
and Synechocystis 6803 make the latter an ideal system for studying the molecular mechanisms 
underlying stress responses and stress adaptation in higher plants18. More importantly, this 
species is naturally competent (homologous recombination at high frequency)19. The recent 
developments in synthetic biology have provided plenty of molecular biology tools to engineer 
Synechocystis 6803 as a photosynthetic host for the production of diverse types of chemicals.   
Metabolic engineering has been applied for microbial ethanol production, including 
overexpression of genes to increase ethanol yield, disruption of genes to direct the carbon flux to 
ethanol and deletion of enzymes that can oxidize NADH. To directly convert CO2 to biofuel, the 
cyanobacterium Synechococcus sp. PCC 7002 was engineered for the synthesis of ethanol 20. 
Recently, pdc and adh genes from Zymomonas mobilis were integrated into the chromosome of 
Synechocystis sp. PCC6803 under the control of the strong light driven psbA2 promoter.  An 
average yield of 5.2 mmol ethanol OD730 unit-1 litre-1 day-1 was achieved 21. Algenol Biofuels 
Inc. claim that they can produce ethanol at a rate of 6000 gal/acre/year from an engineered 
cyanobacterial strain22.  
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Butanol is hydrophobic, has greater energy density, and a higher octane rating relative to 
ethanol. Therefore, butanol biosynthesis has received extensive studies. Acetone-butanol-ethanol 
(ABE) fermentation uses Clostridium acetobutylicum to produce n-butanol, but such process is 
restrained by relatively low production rate and generates large amount of byproducts. To 
overcome this problem, the n-butanol pathway derived from Clostridium was reconstructed in 
fast-growing E. coli or yeast strains 23, 24. Another novel alcohol synthesis approach is via non-
fermentative pathway25, where the amino acids biosynthesis pathways and Ehrlich pathway 26, 27 
were utilized to convert glucose to alcohols. Cyanobacteria have been explored for biofuel 
production (Figure 1.2). Synechococcus elongatus PCC 7942 was engineered to accumulate 450 
mg/L of isobutanol in 6 days28. S. elongatus 7942 was engineered with a modified CoA-
dependent 1-butanol pathway and this strain accumulated 14.5 mg/L 1-butanol under anoxic 
condition29. Long chain alcohols and hydrocarbons have ideal properties for combustion and are 
found to be either additives or major components of petroleum.  Synechocystis 6803 and 
Arabidospis thaliana were engineered with a heterologous fatty acyl-CoA reductase (FAR) for 
the production of fatty alcohols30.  Researchers at LS9 identified two key enzymes responsible 
for the production of alkanes in cyanobacteria: an acyl-CoA carboxylase and an aldehyde 
decarbonylase 31. This discovery opens up many possibilities for engineering cyanobacteria for 
alkane production.  
9 
 
 
 
Figure 1.2:  Schematic representation of engineered biochemical pathways for the production of 
biofuels in cyanobacteria. Abbreviations: RuBP, Ribulose-1,5-bisphosphate3-PGA; 3-
phosphoglycerate; Kdc, ketoacid decarboxylase; ADH, alcohol dehydrogenase; PDC , pyruvate 
decarboxylase; ACC, acetyl-CoA carboxylase; AAR, acyl-ACP reductase; AAD, aldehyde 
decarbonylase; FAR, fatty acyl-CoA reductase; Ter, trans-2-enoyl-CoA reductase; Hbd, 3-
hydroxybutyryl-CoA dehydrogenase; AdhE2, aldehyde/alcoholdehydrogenase; LDH, lactate 
dehydrogenase; EFE, Ethylene formation enzyme. Highlighted reactions indicate the pathway 
that will be focused in this study. 
 
Finally, many of the cyanobacterial strains have native hydrogenases that can evolve 
hydrogen under anoxic conditions.  Though the theoretical efficiency for hydrogen production is 
predicted to be high, the efficiency in which wild type cyanobacterial strains produce hydrogen 
was observed to be very low (< 0.1%) 13.  Synechococcus elongatus sp. 7942 was engineered 
with hydrogenase from Clostridium acetobutylicum and was demonstrated that the 
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heterogeneous hydrogenase can support hydrogen evolution at a rate >500 times than that of 
endogenous hydrogenase under anoxic conditions32. 
 
1.5 Modeling and Systems Analysis  
Mathematical kinetic models can be helpful in interpreting experimental data, in 
understanding quantitative functions of biological systems, and in predicting metabolic 
performances 33.  Arnold Fredrickson introduced the terms “segregated” and “structured” to 
categorize most kinetic models for biological systems.  The term “segregated” was used to take 
into account the presence of heterogeneous individuals in a cell population explicitly (For 
example: a model that would take into account the different age groups of cell that would be 
present in a cell population). The “structured” kinetic model was used to define formulation of 
cell systems as composed of multiple biomass components. The group “Unsegregated and 
unstructured” is the most idealized case which considers the cell population as one component 
solute and most of the kinetic models will fall in this category (e.g.,  Michaelis-Menten kinetics: 
V=Vm×S/(Km+S) 34).  
On the other hand, metabolic fluxes do not consider kinetic behavior of microorganisms, 
but they provide the ratios in which each pathway is engaged in cellular functions.  Fluxomics in 
an organism were first studied using in silico analysis known as Flux Balance Analysis (FBA).  
FBA uses the stoichiometry of metabolic reactions along with a set of constraints34. The total 
number of reactions and constraints is often less than the number of variables (Flux) to be 
calculated and hence the system is underdetermined.  This necessitates the use of an objective 
function to calculate the set of theoretical fluxes.  Maximization of biomass is the objective 
function employed generally as all species evolve themselves to multiply more in their 
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environment. 13C-MFA computes the overall pathway activities in an organism by utilizing the 
isotopic labeling approach and is valid only at isotopic and metabolic steady state. 13C-MFA is 
performed by feeding the microbes with a 13C labeled carbon source followed by measurement 
of the enrichment pattern of the metabolites.  The isotopic labeling pattern of all the metabolites 
is then fed to an algorithm to generate the intracellular fluxes34.  Though both the methods of 
FBA and 13C-MFA utilize the overall metabolic network and use the assumption of metabolic 
steady state, they have two different purposes. FBA gives an optimal flux distribution to achieve 
a desired performance whereas 13C-MFA quantifies the in vivo operation of a cell.  The two 
techniques complement each other and can be utilized to locate bottlenecks in metabolic 
pathways for the synthesis of a desired product (Figure 1.3).  
Finally, the current flux analysis disregards the dynamic metabolic behavior of a 
biological system. This avoids the difficulties in solving large-scale kinetic models and 
performing time-dependent experimental measurements. However, many biological systems 
cannot maintain a metabolic (or isotopic) steady state during the entire cultivation process. The 
flux modeling for dynamic metabolite concentrations or isotopic labeling requires the innovative 
approaches to link kinetic model to metabolic flux analysis. 
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Figure 1.3:  Metabolic network modeling and analysis. FBA profiles the "optimal" metabolism 
for the desired performance (can be genome-scale); 13C-MFA measures in vivo operation of the 
central metabolic network (< 100 reactions). 
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Chapter 2: Statistics-based model for prediction of chemical 
biosynthesis yield from Saccharomyces cerevisiae 
This chapter has been reproduced from the following publication: 
Varman, A.M., Xiao, Y., Leonard, E. & Tang, Y. Statistics-based model for prediction of 
chemical biosynthesis yield from Saccharomyces cerevisiae. Microbial Cell Factories 10, 45 
(2011). 
 
 
Abstract 
Background 
     The robustness of Saccharomyces cerevisiae in facilitating industrial-scale production of 
ethanol extends its utilization as a platform to synthesize other metabolites, both native and of 
heterologous origins. Metabolic engineering strategies, typically via pathway overexpression and 
deletion, continue to play a key role for optimizing the conversion efficiency of substrates into 
the desired products. However, chemical production titer or yield remains difficult to predict 
based on reaction stoichiometry and mass balance. We sampled a large space of data of chemical 
production from S. cerevisiae, and developed a statistics-based model to calculate production 
yield using input variables that represent the number of enzymatic steps in the key biosynthetic 
pathway of interest, metabolic modifications, cultivation modes, nutrition and oxygen 
availability. 
Results 
     Based on the production data of about 40 chemicals produced from S. cerevisiae, metabolic 
engineering methods, metabolite supplementation, and fermentation conditions described 
therein, we generated mathematical models with numerical and categorical variables to predict 
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production yield. Statistically, the models showed that: 1. Chemical production from central 
metabolic precursors decreased exponentially with increasing number of enzymatic steps for 
biosynthesis (>30% loss of yield per enzymatic step, P-value=0); 2. Categorical variables of gene 
overexpression and knockout improved product yield by 2~4 folds (P-value<0.1); 3. Addition of 
notable amount of intermediate precursors or nutrients improved product yield by over five folds 
(P-value<0.05); 4. Performing the cultivation in a bioreactor enhanced the yield of product by 
three folds (P-value<0.05); 5. Contribution of oxygen to product yield was not statistically 
significant. Yield calculations for various chemicals using the linear model were in fairly good 
agreement with the experimental values. The model generally underestimated the ethanol 
production as compared to other chemicals, which supported the notion that the metabolism of 
Saccharomyces cerevisiae has historically evolved for robust alcohol fermentation.  
Conclusions   
     We generated simple mathematical models for first-order approximation of chemical 
production yield from S. cerevisiae. These linear models provide empirical insights to the effects 
of strain engineering and cultivation conditions toward biosynthetic efficiency. These models 
may not only provide guidelines for metabolic engineers to synthesize desired products, but also 
be useful to compare the biosynthesis performance among different research papers.  
2.1 Background 
 
           Producing small-molecule chemicals from microbial biocatalysts offers several 
advantages. Unlike conventional chemical synthesis which are heavily dependent on petroleum-
derived substrates, microbes are able to use renewable materials to synthesize many commodity 
15 
 
 
chemicals and fuels 7 (Figure 2.1). Due to its scalability, microorganisms are also suitable 
platforms to synthesize pharmaceutical molecules that are conventionally produced from 
extracting large amounts of natural resources. Among many industrial microorganisms, the 
baker’s yeast, i.e., S. cerevisiae continues to emerge as a preferred production platform 35. S. 
cerevisiae is typically known for its robustness in fermenting sugars into alcohol. In the recent 
past, it has also gained importance as a heterologous platform to synthesize many precursors of 
commodity chemicals and pharmaceuticals 7. In general, chemical production using whole-cell 
biocatalysts are achieved by genetic engineering to extend the substrate range of an existing 
biosynthetic pathway or to introduce new biosynthetic pathways (either derived from other 
organisms, or completely novel). Rational metabolic engineering approaches then analyze the 
cellular metabolism and improve production titer by overexpressing rate-limiting enzymes or 
deleting competing pathways. In general, the actual yield of chemical production is not easily 
predicted due to the complexity of biological systems and dependency of cultivation conditions. 
Biological complexities not only include intrinsic properties (such as enzyme kinetics and 
substrate specificity), but also include enzyme compartmentalization, intracellular signaling, and 
metabolite transport between eukaryotic cell organelles. Therefore, strain engineering requires 
multiple rounds of trial-and-error experiments to perform the optimum combination of genetic 
manipulations. In the present work, we sought to develop mathematical models that could 
provide a priori estimation of chemical production yield from engineered S. cerevisiae when 
given a set of parameters, namely the number of steps in the biosynthetic pathway of interest, 
genetic modifications, cultivation conditions, and nutrient and oxygen availability. The 
coefficients of these parameters were obtained from the regression of the yields and production 
conditions reported by recent literatures. Such model predicted the empirical yields that were 
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lower than the theoretical productivities under “ideal” conditions. The model results could give 
metabolic engineers guidelines for increasing desired products and for reducing futile attempts. 
2.2 Model development 
 
           The model defined several important parameters that influenced the efficiency of 
chemical production from microbial hosts. The first group of parameters accounted for the 
number of enzymatic steps in the biosynthetic pathway of interest since it had been shown that 
this parameter was often inversely correlated with microbial product yield 9. To enumerate the 
number of enzymatic steps, we introduced two numerical variables in our model, i.e. PRI and 
SEC. The variable PRI specified the number of enzymatic steps in primary metabolism (Figure 
2.1), e.g. glycolysis that is required to convert sugar (glucose or galactose) to pyruvate. The 
variable SEC specified the number of enzymatic steps in the subsequent pathway (typically 
belongs to secondary metabolism), which catalyzed the conversion of central carbon 
intermediate into the final product of interest. The next group of variables was to capture the 
effects of genetic modification. Various genetic strategies have been used to implement 
metabolic engineering 4, 34. For example, promoters with different strength influence production 
level. However, for the sake of simplifying our model, variations of genetic components used in 
metabolic engineering strategies were lumped into two ordinal variables, i.e. OVE, and KNO. 
OVE signified the introduction of multiple copies of genes of native or heterologous origin for 
the purpose of improving production level. KNO signifies the alteration of branch pathways that 
might compete with the pathway of interest 5, 36. We further sub-categorized OVE based on the 
number of modified genes into OVEC1 (without “pushing” pathway flux), OVEC2 (enhancing 1~2 
enzyme activities), and OVEC3 (improving a number of key enzyme functions). KNO was also 
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categorized by KNOC1 and KNOC2 (i.e., without knockout or with knockout, respectively). Table 
2.1 explained the specifications for each sub-category.  
The yield of metabolite production is also a function of cultivation conditions and nutrient 
availability. For instance, production of metabolites from a bioreactor is often higher than a 
shaking flask, due to the increased efficiency of mass transfer of oxygen, substrates, and 
nutrients. Moreover, culture acidification that often generates cytotoxicity and maintenance 
burden to the microbial hosts can be mitigated in a bioreactor by automated pH control. Based on 
these basic properties, we introduced the variable CUL to represent the general property of a 
cultivation condition. We also introduced the variable OXY and NUT to capture the effects of 
oxygen availability and nutrient supplementation, respectively37-39. Moreover, the variable INT 
captured the effect of addition of a secondary carbon source which served as a precursor or an 
intermediate metabolite of the pathway of interest.  
Several assumptions were made to simplify our model development. A) Yield calculation was 
based on the conversion of major carbon substrate to final product if multiple nutrient sources 
were supplemented (e.g., yeast extract was not treated as the carbon source). B) We calculated 
the yields based on two factors: initially added carbon substrate in the culture and final measured 
product. We neglected the unused carbon substrate that remained in the end of the production. C) 
To calculate enzymatic steps from the carbon source, the model only considered the key route 
from the major substrate (mostly glucose) to the final products (enzyme steps for co-factors or 
ATPs synthesis were neglected). D) For product synthesis promoted by the addition of an 
intermediate, we had no means of differentiating the carbons derived from added precursor or 
from the carbon substrate (i.e., glucose). To account for the contribution from both carbon 
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sources, the yield calculation was assumed to be an arithmetic mean of the two yields (One yield 
was based on substrate, e.g., glucose, and the other yield was estimated from the intermediates). 
Meanwhile, the number of primary steps or secondary steps were also assumed as an arithmetic 
mean of two data sets (one variable was counted from substrate; the other variable was counted 
from the intermediate).  
Biochemical systems theory 34 states that reaction rates (νi) can be described by a general power 
law expression of the type: 
ijg
i i j
j
ν =α X∏                            (2.1) 
Where Xj  represents the system variables and the parameters αi , gij are the constants.  Equation 
(2.1) yields a linear form in logarithmic coordinates. Based on similar assumptions, our model 
for yield prediction used system variables (i.e., numerical or categorical variables related to yeast 
biosynthesis) to describe the relative carbon flux to the final products. 
log10 Y = β0 + βPRIPRI + βSECSEC + βOVE,C2OVEC2 + βOVE,C3OVEC3 + βKNO,C2KNOC2 + 
βNUT,C2NUTC2 + βINT,C2INTC2 +  βCUL,C2CULC2 + βOXY,C2OXYC2                                      (2.2) 
In Equation 2.2, log10 Y was the dependent variable which represented production yield (mol C 
in product/mol C in primary substrate), given each independent variables βi 40. We defined β0 as 
the intercept in Equation 2.2, which represented the combined contribution of Category 1 of all 
ordinal variables. β0 was defined as: 
β0 = βOVE,C1 + βKNO,C1 + βNUT,C1 + βINT,C1+ βCUL,C1 + βOXY,C1                             (2.3)                                 
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The ordinal variables (using a binary system) were assigned a value of one if and only if the 
condition fitted the category in Table 2.1. Otherwise, the ordinal variables were assigned a value 
of 0 41. (2)  To acquire the coefficients in Equation 2.2 and 2.3, we compiled data from ~40 
publications which described the production of chemicals by S. cerevisiae under various 
experimental conditions. Table 2.2 summarized the categories assigned to these experimental 
conditions and the yield of product from our best judgment. Using these data, we performed 
regression analysis to fit the model via the software package R 42 to find the regression 
coefficients and P-values. For this study, a variable was statistically significant (90%) if its P-
value was below 0.1.  
2.3 Results and discussion 
 
           We constructed simple models which linked several numerical and ordinal variables that 
affected the yield of chemical production from S. cerevisiae. These ordinal variables consisted of 
the number of modified genes or pathways (OVE), the number of gene knockouts in known 
competitive pathways (KNO), nutrient source (NUT), intermediate (INT), cultivation mode 
(CUL), and oxygen availability (OXY). We described the yield of chemical production as the 
summation of these independent variables in Equation 2.2. We fitted Equation 2.2 and 
determined the coefficients of the variables using linear regression analysis of ~40 compounds. 
Although multiple data of production yields were often reported in each literature, the model 
only considered the best yield under a denoted experimental condition. Then, all experimental 
conditions were categorized by numerical and ordinal variables. The linear regression 
coefficients obtained for Equation 2.2 were given in Equation 2.4, such that: 
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log Y = -1.53 -0.01 PRI – 0.19 SEC + 0.007 OVEC2 + 0.52 OVEC3 + 0.31 KNOC2 + 0.73 NUTC2 
+ 0.77 INTC2 + 0.51 CULC2 + 0.27 OXYC2                                                   (2.4) 
The accuracy of obtained coefficients in Equation 2.4 was evaluated based on R2 and the P-
value. Here, we used a P-value of 0.1 as the limit below which the result was considered 
significant 43.  Out of the eight variables specified in our model, SEC, OVE, KNO, NUT, INT 
and CUL had P-value of less than 0.1. The summary of the P-value of each variable was listed in 
Table 2.3. Figure 2.2A showed a plot of the production yields obtained experimentally and those 
obtained from model prediction for the corresponding conditions. The correlation of this model 
to the dataset had an R2 value of 0.55, which reflected the moderate discrepancy between 
reported yields and the model-predicted yields. Figure 2.2B plotted the residuals of model fitting. 
The residuals appeared to scatter around zero randomly, so the linear model was proper to 
describe the experimental data.  
Interestingly, the number of enzymes in the primary pathway (PRI) did not significantly affect 
production yield (P-value = 0.76) (Table 2.3). This suggested that rate-limiting steps to increase 
chemical production flux often lay in the downstream pathway of central metabolism. The 
coefficient of SEC was negative. This suggested that the length of a pathway downstream of 
central metabolism negatively affected production yield. Specifically, addition of a new 
enzymatic step in a secondary metabolic pathway reduced product yield by 36% (for numerical 
variable SEC: 10βSEC =10-0.19 =64%). A good demonstration of the effect of pathway length on 
product yield was found in the case of naringenin production 44. With the following inputs of 
variables PRI = 10 (Galactose to PEP), SEC = 14 (i.e., 10 steps from PEP to phenylalanine; 4 
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steps from phenylalanine to flavanone), KNO = INT = CUL = OXY = category 1, NUT = 
Category 2; OVE = Category 3; the model calculated: 
Yield= 10-1.53- (0.01×10) + (-0.19×14) + 0.52+0.73= 0.0009 (The reported experimental production yield was 
0.00058). In most cases, our model-predicted yields were within the range of one order of 
magnitude compared to the experimental values.  
Since the number of steps in central metabolism (PRI) did not significantly affect production 
yield, we computed another set of regression coefficients for Equation 2 without the variable 
PRI, to yield a simplified form Equation 2.5.  
log Y = -1.60 – 0.19 SEC + 0.0003 OVEC2 + 0.50 OVEC3 + 0.31 KNOC2 + 0.73 NUTC2 + 0.82 
INTC2 + 0.51 CULC2 + 0.28 OXYC2                                                           (2.5) 
As shown in Table 2.3, regression using Equation 2 with the exclusion of the variable PRI did 
not change the R2 value. This result indicated that the number of enzymatic steps in primary 
metabolism did not significantly affect product yield. Presumably, fluxes in central metabolic 
pathways were typically high and robust 45, when compared to those downstream secondary 
pathways. It has been demonstrated recently that production of chemicals was significantly 
improved, only when the capacity of a downstream pathway was increased 46. 
Metabolic engineering typically involves pathway modification to shift metabolic fluxes into a 
desired product or to permit the use of an alternative carbon source 47. We defined the variable 
OVE, and KNO in Equation 2.2 to capture the effect of pathway overexpression, and deletion, 
respectively. The regression of experimental data using Equation 2.2 showed that the coefficients 
of OVEC2 and OVEC3 had positive values (Table 2.3). The model successfully captured the 
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contribution of both pathway overexpression and gene deletions to increase product yield in S. 
cerevisiae. The high P-value of OVEC2 (0.98) indicated that statistically, the overexpression of a 
small number of genes (1-2) was uncertain to improve production yield. However, the coefficient 
of OVEC3 (=0.52; P-value=0.07) indicated the effectiveness of multiple gene modification to 
resolve the bottleneck steps. This observation is consistent to the fact that metabolic fluxes 
generally do not sensitively respond to changes of single enzyme activity, but are controlled by 
all key enzymes along the biosynthesis pathway. On the other hand, the regression coefficients of 
KNOC2 had positive value (=0.31, P-value = 0.08), and thus the removal of competitive 
pathways could be effective to increase production yield.  
It is a general knowledge that bioprocess conditions affect cellular viability and product yield. 
Our model suggested fermentation using a well-controlled bioreactor improved production yield 
by 3.2 times (CULC2:10βCUL,C2 = 100.51). The model further suggested that fermentation under 
anaerobic or microaerobic condition could enhance yield compared to aerobic fermentation. 
However, such enhancement was not statistically significant (P-value = 0.32). This observation 
could be explained by the fact that S. cerevisiae produced fermentative products (ethanol and 
glycerol) (Crabtree effect) 48, 49 under aerobic and glucose-sufficient medium. Therefore, aerobic 
metabolism in S. cerevisiae could operate similarly to metabolism under oxygen-limited 
condition. The coefficient for the variable INT was 0.77, which represented that the 
supplementation of a precursor metabolite translated to an approximately six fold increase of the 
product yield (P-value = 0.02). Similarly, the addition of nutrients (such as yeast extract) also 
significantly increased production yield (the coefficient of NUTC2 was 0.73). The contributions 
of INT and NUT to product formation indicated that intermediates/nutrients provided building 
blocks or energy sources that reduced the rate-limiting steps in biosynthetic pathways. 
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We used Equation 2.2 to compute the production yield of chemicals according to the 
specifications listed in Table 2.2. We observed that, for ethanol production, the experimental 
values were generally higher than the empirical model predictions. In reality, the reported 
maximum ethanol yield could reach 0.5 mol C-ethanol / mol C-glucose 50, which could be 
several folds higher than model predictions. To mitigate this discrepancy, we re-categorized the 
ethanol synthesis pathway as the primary pathway to generate Equation 2.6.  
log Y = -1.73 +0.003 PRI – 0.19 SEC + 0.05 OVEC2 + 0.56 OVEC3 + 0.37 KNOC2 + 0.71 NUTC2 
+ 0.86 INTC2 + 0.51 CULC2 + 0.12 OXYC2                     (2.6)  
Regression of the data using Equation 2.6 improved the R2 value from 0.55 to 0.58, 
demonstrating that ethanol could be better assumed as a central metabolite for S. cerevisiae. 
Using Equation 2.6, we predicted ethanol production based on a recent reference  51  by 
specifying PRI = 11, SEC = 1 (cellulose degradation step), OVE = C3, KNO = C1; NUT = C2, 
INT = C1, CUL = C1, and OXY = C2. The ethanol production yield calculated by Equation 2.6 
was 0.31. This value was in good agreement with the reported values of ~0.4 51.    
2.4 Model applications and limitations 
 
            The main application of the model is to predict the biosynthesis yield from S. cerevisiae. 
The model were validated by “unseen data” (Figure 2.2C) from some randomly selected new 
publications (2010~2011). The model predicted the yields based on the reported experimental 
conditions described by these papers 52-56. Most yield data were close to model predictions. The 
predictive power of the model was consistent with the model quality described in Table 2.3.  
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Furthermore, the model can reveal the metabolic features of S. cerevisiae. For example, the 
modified model Equation 2.6 showed that it was better to treat ethanol pathway as the primary 
routes in cell metabolism, because of the strong ability for ethanol fermentation by yeast, 
possibly due to long-term process for selecting yeast as alcohol producer through human history. 
The model can also be useful for comparing the productivity among other yeast species (Figure 
2.3). For example, riboflavin producer, Candida famata, exhibits a high riboflavin productivity 
(2~3 order of magnitude higher than model prediction) 57. Pichia pastoris, a common species for 
protein expression, shows high S-adenosyl-L-methionine productivity if a large amount of the 
intermediate methionine was repeatedly added in the medium 58.  Besides, Pichia stipitis also has 
high yields of L-lactic acid and ethanol from glucose and xylose 59.  Figure 2.3 demonstrated that 
some yeast species were able to explore their native pathways for biosynthesis of certain 
products with extraordinary efficiency (better than S. cerevisiae), therefore, these yeast species 
may be alternative hosts for certain biotechnology applications.  
The accuracy of the model predictions for some products could be poor due to several limitations 
during model development. First, the category was a rough estimation of experimental conditions 
especially for variables related to gene modifications (OVE and KNO), and the yields could be 
very different even in the same category. Second, some products, despite large synthesis rates, 
were either not very stable or difficult to accumulate in a large quantity due to consumptions by 
downstream pathways or product degradations (e.g., Glycerol 3-phosphate 60). Their yields could 
be significantly lower than model predictions even though the actual flux to the product was 
high. Third, the coefficient βSEC from model regression could not account for the big variances of 
biosynthesis efficiency or potentially feedback inhibitions in secondary pathways. For example, 
butanol synthesis is significantly improved via non-fermentative amino acid pathways compared 
25 
 
 
to traditional acetyl-CoA routes 61, because amino acid synthesis pathways in microorganisms 
are more effective than other heterogeneous pathways. Fourth, because of limited information 
from the references, the yield calculation could not precisely include the CO2 fixation (e.g., 
overexpression of the native carboxylase pathway: pyruvate + CO2  oxaloacetate) 62 or the 
nutrients utilization in the rich medium. Fifth, the model neglected enzyme steps related to 
energy metabolism (such as ATP and NADPH synthesis), while cofactor imbalance can also 
affect the product yields.   
2.5 Comparison to the previously published E. coli model 63 
     
            Recently, we have constructed the E.coli model using same modeling approach. 
Compared to the E.coli model, S. cerevisiae shows several differences: 1. Oxygen conditions 
made a more significant impact on biosynthesis yield in E.coli than that in S. cerevisiae; 2. The 
genetic modification in E.coli had higher uncertainty for metabolic outcomes; 3. For metabolic 
pathways from precursors to final products, loss of yield per biosynthesis step (~30%) in S. 
cerevisiae is higher than that in E.coli (10~20%). Interestingly, E. coli model states that primary 
metabolism influences product yield (a relatively small P-value of 0.06) which indicates the 
balance of precursor production from central metabolism is also an important consideration for 
metabolic engineering of E.coli. For example, it has been demonstrated that lycopene production 
with E. coli was enhanced by redirecting the carbon flux from pyruvate to G3P 64, but feeding 
other central metabolite precursors (such as pyruvate) could not improve lycopene production. 
On the other hand, the S. cerevisiae model indicates that it is less likely that the number of steps 
in central metabolism play a bottleneck role in the production of metabolites derived from it, 
while the bottlenecks are more likely in the secondary pathways (from central precursors to the 
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final product). Therefore, the metabolic strategies should focus on the secondary pathways to 
have a better chance for increasing final yield. Although modification of central metabolism may 
affect microbial physiologies, a few studies indicate the robustness of the central metabolism in 
S. cerevisiae because of its importance to cell vitality. For example, S. cerevisiae may maintain 
central metabolic fluxes via gene duplication and alternative pathways under different 
environmental and physiological conditions 45, 65. Therefore, the inflexibility of central pathways 
in S. cerevisiae is likely to render metabolic engineering strategies ineffective when targeting 
enzymes in central metabolism. In general, the unique metabolic features of yeast and bacteria 
can be of important consideration when choosing a production host. 
2.6 Conclusions 
 
           Although S. cerevisiae has been widely used as a robust industrial organism for metabolic 
engineering applications, many metabolic features of this organism for biosynthesis under 
various conditions remain unknown. In this study, the statistic model for yeast biosynthesis 
permits a priori calculation of the final product yield achievable by current biotechnology. 
Unlike other in silico models based on mass balance or thermodynamics (such as FBA model) 66, 
67, our model is based on a statistical analysis of published data using numerical and ordinal 
variables (categorized experimental conditions). The model has three applications. 1. The yield 
prediction takes into account the genetic design of the microbial host system and the 
“suboptimal” conditions under which the fermentation process occurs.  2. The model may 
identify effective metabolic strategies and at the same time, quantitatively provide the degree of 
uncertainty (i.e., possibility for failure). For example, statistical analysis shows that, for S. 
cerevisiae, metabolic bottlenecks may be more likely to be in the secondary metabolic pathways 
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rather than primary pathways, and thus it can narrow down the genetic targets and avoid futile 
work. 3. This model may be used to qualitatively benchmark yields of different engineered 
production platforms. 
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Figure 2.1:  Metabolic pathway for the biosynthesis of major products. The blue box represents 
central metabolism and the yellow box represents secondary metabolism.  Solid arrows signify 
single step reaction and dotted arrows signify multiple steps. Abbreviations: ACoA  –  Acetyl-
CoA; DAP – Dihydroxyacetone-Phosphate; DAHP – 3-Deoxy-D-Arabino-Heptulosonate-7-
Phosphate; DHA – Dihydroxyacetone; F6P -  Fructose-6-Phosphate; FBP – Fructose 1,6-
bisphosphate; G6P – Glucose-6-Phosphate; GADP – Glyceraldehyde-3-Phosphate; Oxa – 
Oxaloacetate; Oxo – 2-Oxoglutarate; PEP – Phosphoenolpyruvate; PHB – Poly[(R)-3-
hydroxybutyrate]; pHCA – p-Hydroxycinnamic acid; R5P – Ribose-5-Phosphate; Ru5P – 
Ribulose-5-Phosphate; Suc – Succinate; X5P – Xylulose-5- Phosphate. 
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Figure 2.2 A 
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Figure 2.2 C 
 
 
                                                                           
Figure 2.2:  Model results. A) Plot of the actual logarithmic yields against the logarithmic yields 
generated by the regression model. The line drawn as diagonal to the plot is one-to-one and 
passes through the origin. The data points have an R2 value of 0.55. B) Plot of residuals against 
fitted values. C) Model validation using newly published data (2010~2011) 1 - β-amyrin 52; 2 - 
ascorbic acid 53; 3 – monoterpene 54; 4 – vanillin 55; 5 - succinic acid 56. 
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Figure 2.3:  S. cerevisiae model prediction of biosynthesis yields for other industrial yeast 
species 57-59, 68-70.    Ethanol:      or       .   L-lactic acid:     .       Lycopene:     . Riboflavin: + or X .  
S-adenosyl-L-methionine:  ─ . 
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Table 2.1:  Ordinal variables used in the linear regression model 
Ordinal variables Category 1 
(subscript C1) 
Category 2 
(subscript C2) 
Category 3 
(subscript C3) 
OVE: number of 
modified genes or 
pathways 
No modified genes or 
pathways were 
present. 
One or two modified 
genes or pathways 
were present. 
More than two 
modified genes or 
pathways were 
present. 
KNO: number of gene 
knockouts in known 
competitive pathways 
No gene knockouts 
were performed. 
Gene knockouts were 
performed. 
 
NUT: nutrient source Fermentation 
occurred in defined 
medium (only 
including trace 
amounts of amino 
acids or vitamins) 
Fermentation 
occurred in a very 
rich medium. 
 
INT: Intermediate Intermediate was not 
added 
Intermediate was 
added 
 
CUL: cultivation 
mode 
Fermentation 
occurred in a shaking 
flask. 
Fermentation 
occurred in a batch, 
fed-batch, or 
continuous feed 
bioreactor. 
 
OXY: oxygen 
conditions 
Fermentation 
occurred in aerobic 
conditions. 
Fermentation 
occurred under 
oxygen-limited 
conditions (anaerobic 
or micro-aerobic). 
 
 
 
Note: the input of ordinal variables was specified using a binary system, 1 and 0. When a 
category (e.g., overexpression Category 2) was applied, the value 1 was assigned to OVEC2. 
Otherwise, the value 0 was assigned. 
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Table 2.2:  Dataset used for linear regression 
 
 
Reference Product Yield 
Primary 
Step 
Second 
Step OVE_C2 OVE_C3 KNO_C2 NUT_C2 INT_C2 CUL_C2 OXY_C2 
71
 (E,E,E)-Geranylgeraniol 0.00025 10 10 1 0 0 1 0 0 0 
71
 (E,E,E)-Geranylgeraniol 0.014 10 10 0 1 0 1 0 0 0 
71
 (E,E,E)-Geranylgeraniol 0.047 10 10 0 1 0 1 0 0 0 
71
 (E,E,E)-Geranylgeraniol 0.018 10 10 0 1 0 1 0 0 0 
71
 (E,E,E)-Geranylgeraniol 0.031 10 10 0 1 0 1 0 0 0 
71
 (E,E,E)-Geranylgeraniol 0.058 10 10 0 1 0 1 0 0 0 
71
 (E,E,E)-Geranylgeraniol 0.14 10 10 0 1 0 1 0 1 0 
72
 1,2-Propanediol 0.014 4 3 1 0 0 1 0 0 0 
73
 1,2-Propanediol 0.010 4 3 1 0 0 1 0 1 0 
73
 1,2-Propanediol 0.026 4 3 1 0 0 1 0 1 0 
74
 5-epi-aristolochene 0.010 10 9 1 0 1 1 0        0 0 
74
 5-epi-aristolochene 0.0090 10 9 1 0 1 1 0 0 0 
75
 Acetate 0.13 9 2 0 0 1 0 0 1 0 
76
 Acetate 0.015 9 2 0 0 1 0 0 1 0 
77
 Acetate 0.26 9 2 0 1 0 0 0 0 1 
78
 Amorphadiene 0.00049 12 9 1 0 0 0 0 0 0 
78
 Amorphadiene 0.0020 12 9 1 0 0 0 0 0 0 
78
 Amorphadiene 0.0040 12 9 1 0 1 0 0 0 0 
78
 Amorphadiene 0.011 12 9 1 0 1 0 0 0 0 
78
 Amorphadiene 0.016 12 9 0 1 1 0 0 0 0 
78
 Amorphadiene 0.016 12 9 0 1 1 0 0 0 0 
79
 Amorphadiene 0.0080 12 9 1 0 1 0 0 0 0 
79
 Amorphadiene 0.0090 12 9 0 1 1 0 0 0 0 
79
 Amorphadiene 0.011 12 9 0 1 1 0 0 0 0 
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79
 Amorphadiene 0.013 12 9 0 1 1 0 0 0 0 
78
 Artemisinic acid 0.0030 12 10 0 1 1 0 0 0 0 
78
 Artemisinic acid 0.011 12 10 0 1 1 0 0 1 0 
80
 Cyanophycin 0.12 10(0) 2(1) 1 0 1 1 1 0 0 
80
 Cyanophycin 0.10 10(0) 2(1) 1 0 1 1 1 0 0 
80
 Cyanophycin 0.15 10(0) 2(1) 1 0 1 1 1 0 0 
81
 Dihydroxyacetone 0.0040 4 3 1 0 0 0 0 0 0 
81
 Dihydroxyacetone 0.034 4 3 1 0 1 0 0 0 0 
82
 D-Lactic acid 0.61 9 1 1 0 1 1 0 0 1 
83
 Dolichol 0.00010 10 11 0 0 0 1 0 0 0 
83
 Dolichol 0.00018 10 11 1 0 0 0 0 0 0 
83
 Ergosterol  0.00015 10 21 0 0 0 1 0 0 0 
83
 Ergosterol  0.00020 10 21 1 0 0 0 0 0 0 
50
 Ethanol 0.55 9 2 1 0 0 0 0 1 1 
50
 Ethanol 0.47 8 2 0 1 0 0 0 1 1 
84
 Ethanol 0.080 8 2 0 1 0 0 0 1 0 
84
 Ethanol 0.12 8 2 0 1 0 0 0 1 1 
84
 Ethanol 0.15 8 2 0 1 0 0 0 1 1 
85
 Ethanol 0.53 9 2 1 0 0 1 0 0 0 
85
 Ethanol 0.20 9 2 1 0 0 1 0 0 0 
85
 Ethanol 0.47 9 2 1 0 0 1 0 0 0 
85
 Ethanol 0.42 9 2 0 0 0 1 0 0 0 
85
 Ethanol 0.36 9 2 0 0 0 1 0 0 0 
76
 Ethanol 0.44 9 2 0 0 1 0 0 1 0 
76
 Ethanol 0.32 8 2 0 0 1 0 0 1 1 
86
 Ethanol 0.52 9 2 1 0 0 0 0 0 0 
77
 Ethanol 0.55 9 2 0 1 0 0 0 0 1 
77
 Ethanol 0.39 9 2 0 1 0 0 0 0 1 
77
 Ethanol 0.51 9 2 0 1 1 0 0 0 1 
87
 Ethylene* 0.00069 13 10 1 0 0 0 0 1 0 
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74
 Farnesol 0.036 10 9 0 0 1 1 0 0 0 
88
 Flavanones 0.030 10(0) 14(3) 0 1 0 0 1 0 0 
88
 Flavanones 0.053 10(0) 14(3) 0 1 0 0 1 0 0 
89
 Formate 0.00024 6 7 0 0 1 0 0 0 0 
89
 Formate 0.00030 6 7 0 0 1 0 0 0 0 
90
 Geraniol 0.00011 10 8 1 0 0 0 0 0 0 
90
 Geraniol 0.00019 10 8 1 0 1 0 0 0 0 
90
 Geraniol 0.00019 10 8 1 0 1 0 0 0 0 
91
 Glycerol 0.12 4 2 1 0 0 0 0 1 0 
91
 Glycerol 0.12 4 2 1 0 0 0 0 1 0 
75
 Glycerol 0.41 4 2 1 0 1 0 0 1 0 
75
 Glycerol 0.45 4 2 1 0 1 0 0 1 0 
75
 Glycerol 0.45 4 2 1 0 1 0 0 0 0 
92
 Glycerol 0.49 4 2 0 0 1 1 0 1 0 
92
 Glycerol 0.41 4 2 0 0 1 1 0 1 0 
76
 Glycerol 0.050 4 2 0 0 1 0 0 1 0 
76
 Glycerol 0.037 2 4 0 0 1 0 0 1 1 
93
 Glycerol 0.45 4 2 0 0 1 0 0 1 0 
93
 Glycerol 0.54 4 2 1 0 1 0 0 1 0 
60
 Glycerol 3-phosphate 0.0010 4 1 1 0 1 0 0 0 1 
94
 Hydrocortisone 0.0020 10(0) 19(2) 1 0 0 1 1 0 0 
94
 Hydrocortisone 0.0020 10(0) 19(2) 1 0 1 1 1 0 0 
94
 Hydrocortisone 0.021 10(0) 19(2) 1 0 1 1 1 0 0 
94
 Hydrocortisone 0.026 10(0) 19(2) 1 0 1 1 1 0 0 
95
 Lactate 0.44 9 1 1 0 0 1 0 1 0 
96
 Lactate 0.21 9 1 1 0 0 0 0 1 0 
97
 L-Ascorbic acid 0.14 2(0) 8(2) 1 0 0 0 1 0 0 
97
 L-Ascorbic acid 0.066 2(0) 8(2) 1 0 0 0 1 0 0 
90
 Linalool 8.8 x 10-5 10 8 1 0 0 0 0 0 0 
90
 Linalool 2.3 x 10-5 10 8 1 0 1 0 0 0 0 
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98
 L-Lactic Acid 0.65 9 1 1 0 1 1 0 0 0 
62
 Malate 0.28 11 0 0 1 0 0 0 0 0 
79
 Mevalonate 0.022 12 3 0 1 1 0 0 0 0 
79
 Mevalonate 0.022 12 3 0 1 1 0 0 0 0 
99
 Naringenin 0.0070 8(0) 15(3) 0 1 0 0 1 0 0 
99
 Naringenin 0.0020 8(0) 15(5) 0 1 0 0 1 0 0 
44
 Naringenin 0.00058 10 14 0 1 0 1 0 0 0 
23
 n-Butanol 0.00020 12 6 0 1 0 0 0 0 1 
99
 p-Coumaric Acid 0.033 8(0) 12(2) 0 1 0 0 1 0 0 
100
 p-Hydroxycinnamic acid 0.00020 8 12 1 0 0 0 0 0 0 
100
 p-Hydroxycinnamic acid 0.20 8(0) 12(2) 1 0 0 0 1 0 0 
44
 Pinocembrin 6.6x10-5 10 14 0 1 0 1 0 0 0 
101
 Poly[(R)-3-hydroxybutyrate] 0.00056 10 3 1 0 0 0 0 0 0 
101
 Poly[(R)-3-hydroxybutyrate] 0.003 10 3 1 0 0 0 0 0 0 
101
 Poly[(R)-3-hydroxybutyrate] 0.012 10 3 0 1 0 0 0 0 0 
101
 Poly[(R)-3-hydroxybutyrate] 0.00047 10 3 1 0 0 0 0 1 0 
101
 Poly[(R)-3-hydroxybutyrate] 0.0090 10 3 1 0 0 0 0 1 0 
101
 Poly[(R)-3-hydroxybutyrate] 0.018 10 3 0 1 0 0 0 1 0 
101
 Poly[(R)-3-hydroxybutyrate] 0.0010 10 3 0 1 0 0 0 1 1 
101
 Poly[(R)-3-hydroxybutyrate] 0.017 10 3 0 1 0 1 0 0 0 
74
 Premnaspirodiene 0.011 10 9 1 0 1 1 0 0 0 
74
 Premnaspirodiene 0.0090 10 9 1 0 1 1 0 0 0 
102
 Pyruvate 0.55 9 0 0 0 1 0 0 1 0 
76
 Pyruvate 0.0050 9 0 0 0 1 0 0 1 0 
103
 Reticuline 0.051 8(0) 16(3) 0 1 0 0 1 0 0 
104
 Ribitol 0.0020 5 2 0 0 1 0 0 0 0 
104
 Ribitol 0.027 5 2 1 0 1 0 0 0 0 
104
 Ribitol 0.017 5 2 1 0 1 0 0 0 0 
104
 Ribitol 0.021 5 2 1 0 1 0 0 0 0 
71
 Squalene 0.042 10 9 1 0 0 1 0 0 0 
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105
 Taxadiene 7.7x10-5 12 8 0 1 0 1 0 0 0 
106
 Vanillin 0.0030 3 6 0 1 1 1 0 0 0 
104
 Xylitol 0.0070 5 2 1 0 1 0 0 0 0 
104
 Xylitol 0.014 5 2 1 0 1 0 0 0 0 
104
 Xylitol 0.014 5 2 1 0 1 0 0 0 0 
77
 Xylitol 0.27 5 2 0 1 0 0 0 0 1 
77
 Xylitol 0.29 5 2 0 1 1 0 0 0 1 
107
 β-carotene 4.5x10-7 10 14 1 0 0 0 0 0 0 
107
 β-carotene 2.9x10-6 10 14 0 1 0 0 0 0 0 
107
 β-carotene 0.00011 10 14 0 1 0 0 0 0 0 
107
 β-carotene 0.00036 10 14 0 1 0 0 0 0 0 
107
 β-carotene 0.0010 10 14 0 1 0 0 0 0 0 
            Note: Some papers show that product biosynthesis can be enhanced by supplementing additional precursors.  In the parenthesis, we 
have listed the number of enzyme steps from the added intermediates to final products.  
* Steps for ethylene were counted based on the arginine route.
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Table 2.3:  Regression coefficients and P-values for S. Cerevisiae model 
 
Variable 
Model 1 
With primary steps 
Model 2 
Without primary steps 
Model 3 
Ethanol as a primary metabolite 
Coefficient P-value Std. Error Coefficient P-value Std. Error Coefficient P-value Std. Error 
Intercept -1.53 0 0.42 -1.60 0 0.34  -1.73 0 0.41  
Primary 
step -0.01 0.76 0.04 - - -  0.003 0.93    0.03 
 
Secondary 
step -0.19 0 0.02  -0.19 0 0.02  -0.19 0 0.02 
 
OVE C2 0.007 0.98 0.26  0.0003 0.99 0.25  0.05 0.84 0.24  
OVE C3 0.52 0.07 0.29  0.50 0.079 0.28  0.56 0.05 0.28  
KNO C2 0.31 0.08 0.18  0.31 0.078 0.18  0.37 0.03 0.17  
NUT C2 0.73 0 0.18  0.73 0 0.18  0.71 0 0.17  
INT C2 0.77 0.02 0.31  0.82 0.001 0.25  0.86 0.004 0.29  
CUL C2 0.51 0.02 0.22  0.51 0.02 0.21  0.51 0.02 0.21  
OXY C2 0.27 0.32 0.27  0.28 0.31 0.27  0.12 0.65 0.27  
Multiple R2 0.55                       0.55                         0.58   
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Chapter 3: The use of 13C-based analysis to elucidate the 1 
intrinsic biosynthesis yields 2 
This chapter has been submitted for peer-review and the author would like to thank all the co-3 
authors for their contributions. 4 
 5 
Abstract 6 
Microbial platforms have widely been used for the synthesis of diverse value-added 7 
chemicals. Rational metabolic engineering and optimal fermentations can improve microbial cell 8 
factory’s yields from renewable feedstock. However, very few studies have rigorously 9 
investigated the intrinsic product yields from engineered microbial platforms under complex 10 
cultivation conditions. In this paper, we discuss the use of 13C-based metabolite analysis for 11 
assessment of product yields in four different cases. First, in the rich medium fermentation, 12 
undefined nutrients (such as yeast extract) may also contribute to the synthesis of final product. 13 
Second, product synthesis may be dependent on co-metabolism of multiple-feedstock. Third, 14 
multiple pathways may be employed by microbes for product synthesis. Fourth, the loss of 15 
ATP/NADH due to cell maintenance and low P/O ratio (Phosphate/Oxygen Ratio) reduces 16 
product yields, while 13C-metabolic flux analysis (13C-MFA) can assess the influence of 17 
suboptimal energy metabolism on microbial productivity. Since product yield is a major 18 
determining factor in biotechnology commercialization, we foresee that 13C-isotopic labeling 19 
experiments, even without performing extensive 13C-flux calculations, can play valuable roles in 20 
the development of microbial cell factories.   21 
 22 
Keywords: cell maintenance, co-metabolism, metabolic flux analysis, P/O ratio, yeast extract 23 
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3.1 Introduction 1 
 2 
Recent advances in metabolic engineering has enabled us to engineer microbial cell factories 3 
for the efficient synthesis of diverse products, including bulk chemicals, drugs and fuels 108. For 4 
example, advanced biofuels produced by engineered microorganisms with properties similar to 5 
that of petroleum-based fuels, are being reported extensively 25, 109-112. The emergence of systems 6 
biology and synthetic biology has greatly increased the potential of microbial cell factories 7 
towards the production of value-added chemicals 113. This has also improved product’s yield, 8 
titer, and rate so that microbial cell factories can be moved from lab scale to industrial 9 
fermentations 114, 115. The product yield is a key indicator in achieving an economical bio-10 
production of the bulk and commodity chemicals 116. But, estimation of product yield may be 11 
difficult if fermentations use either rich-mediums or multiple feedstock (Figure 3.1). Moreover, 12 
new pathways/enzymes are often employed to improve microbial productivity and their relative 13 
contribution to product yield remains unknown 24, 109, 117, 118. Thereby, a proper technique for the 14 
quantification of intrinsic yields from the engineered pathways is needed if multiple biosynthesis 15 
routes are used by microbial hosts.  16 
13C-tracing experiments can rigorously determine the in vivo carbon fluxes from specific 17 
substrates to final products. Feeding microbial cultures with 13C-labeled substrates results in 18 
unique isotopic patterns amongst the cell metabolites (isotopic fingerprints) 119, which can 19 
provide functional characterization of metabolic pathways 120. Integration of this isotopomer data 20 
with metabolic modeling (i.e., 13C-MFA) can be used to predict cellular metabolic fluxes. The 21 
metabolic fluxes not only reveals metabolic responses to product synthesis and growth 22 
conditions  121, 122, but can also reveal the rigid metabolic nodes for rational pathway engineering 23 
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123. Therefore, 13C-based analysis (i.e., pathway tracing and 13C-MFA) are widely used in the 1 
field of biotechnology 124-127. Besides these common applications, this paper demonstrates the 2 
additional utility of simple 13C-experiments or the more complicated 13C-MFA in determining 3 
product yields from microbial cell factories. 4 
5 
Figure 3.1:  Schematic description of microbial metabolism.  Many microbes have the ability to 6 
co-metabolize diverse feedstock.  Dark circles indicate labelled carbon.  The enrichment of 7 
labeling in the product acts as an indicator for the relative uptake flux of sugars. 8 
 9 
3.2 Product yield using rich medium 10 
 11 
Engineered microbes may have many metabolic burdens that can inhibit both biomass 12 
growth and product synthesis. To promote their productivity, rich media are commonly used in 13 
fermentations as they provide diverse nutrients for cell growth and stabilize the production 14 
performance of the microbe 114, 115. Thereby, rich mediums include both primary carbon 15 
substrates (e.g., sugars) and large amounts of nutrients (such as yeast extract). Multiple studies 16 
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have revealed that supplementing culture medium with yeast extract or terrific broth to 1 
engineered microbes significantly improves their final biosynthesis yields 63, 128. Since nutrient 2 
supplements can provide undefined building blocks for both biomass and product synthesis, it is 3 
difficult to precisely calculate the actual product yield from the rich-medium fermentation. To 4 
overcome this problem, 13C-analysis can be employed to gain insights into the contributions of 5 
nutrients to product biosynthesis.  6 
For example, two E. coli strains engineered for isobutanol production (i.e., a low 7 
performance strain with an Ehrlich pathway 129 and a high performance JCL260 strain with 8 
overexpression of both the keto-acid pathway and the Ehrlich pathway 130) display an increase in 9 
isobutanol titer with the inclusion of yeast extract in their culture medium. Using fully labeled 10 
glucose and non-labeled yeast extract as carbon sources, 13C-experiments revealed that the low-11 
performance strain derived ~50% of isobutanol carbons from yeast extract (Figure 3.2), while the 12 
JCL260 strain synthesized isobutanol solely from 13C-glucose and used yeast extract mainly for 13 
biomass growth 129. This observation from 13C-analysis indicates that overexpression of keto-14 
acid pathway can resolve the isobutanol synthesis bottleneck and effectively pull the carbon from 15 
glucose to product. In another work, an E.coli strain was engineered for conversion of acetate 16 
into free fatty acids via the overexpression of both acetyl-coA synthetase and the fatty acid 17 
pathways. In the acetate-based fermentation, yeast extract significantly promoted fatty acid 18 
productivity, resulting in 1 g/L fatty acids from ~10g/L acetate 131. 13C-analysis of the culture 19 
with fully labeled acetate and yeast extract has shown that ~63% carbons in the free fatty acids 20 
were synthesized from 13C-acetate (Figure 3.2). Thereby, the actual microbial yield from a 21 
primary substrate in a rich medium could be correctly estimated based on isotopomer analysis.   22 
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 1 
Figure 3.2:  (A) Biosynthesis yield analyzed by feeding cells with 13C-substrates (such as fully 2 
labeled glucose and acetate).  (B) Relative product yields from a primary substrate (a – 3 
Isobutanol from glucose in a low performance strain; ab – valine from glucose in a low 4 
performance strain; b – Isobutanol from glucose in JCL260; bb – valine from glucose in JCL260) 5 
129; c – Free fatty acids from acetate in an E.coli strain 131; d - biomass from glucose in wild type 6 
Synechocystis 6803 132; e - D-lactate from acetate in engineered Synechocystis 6803 133. Relative 7 
yield is calculated based on 13C concentrations in the final product. Abbreviations: GAP, 8 
Glyceraldehyde -3- phosphate; PYR, pyruvate; KIV, ketoisovalerate. 9 
 10 
3.3 Product yield during co-metabolism of multiple carbon substrates 11 
 12 
Algal species are able to utilize both CO2 and organic carbon substrates. Such 13 
mixotrophic metabolism can alleviate the dependence of algal hosts on light and CO2 limitations, 14 
and thus enable them to achieve high biomass growth rate and product titer 134. 13C-metabolite 15 
analysis has been used to track their photomixotrophic metabolisms in different scenarios. For 16 
example, Synechocystis sp. PCC 6803 (blue-green algae) is a model a cyanobacterium which can 17 
be engineered to produce diverse products and has capability to perform photomixotrophic 18 
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metabolism 135. 13C-MFA has shown that CO2 contributes to 25% of Synechocystis biomass yield 1 
during its mixotrophic growth with 13C-glucose and 12CO2 132. Besides, 13C-metabolite analysis 2 
has also been used to track the synthesis of D-lactate in an engineered Synechocystis 6803 133. In 3 
that study, the lactate production was found to be increased substantially during the co-4 
metabolism of both CO2 and acetate. Experiments with fully labeled acetate and 12CO2 5 
discovered that nearly all of lactate molecules were non-labeled and that only the acetyl-CoA-6 
derived proteinogenic amino acids (leucine, glutamate and glutamine) were 13C-labeled. This 7 
result suggested that acetate was involved only in biomass growth, while the yield of D-lactate 8 
was completely derived from CO2. 13C-results also further indicated that acetate may inhibit the 9 
pyruvate decarboxylation reaction and thus redirect flux to lactate. The above study shows the 10 
value of 13C-analysis to improve our understanding of pathway regulations for product synthesis. 11 
Since many microbial platforms (including both algal species and heterotrophs) may co-12 
metabolize multiple carbon substrates simultaneously, isotopomer feeding can reveal the 13 
contributions of each substrate to key metabolite pools, and thus predict the potential bottlenecks 14 
in biomass or product formations.  15 
3.4 Accurate laboratory analysis of product concentrations 16 
 17 
 Direct measurement of product concentrations in the culture can obtain deceptive results. 18 
There are a few cases that cause product measurement errors. First, loss of volatile products 19 
(such as alcohols) during fermentation may reduce product titers. Second, product may be 20 
degraded or consumed by contaminated microbes during fermentation process. For example, 21 
photochemical degradation of isobutanol synthesis from cyanobacteria was reported 136. Third, 22 
aerobic fermentation in shake flasks may have significant water vaporization during long-term 23 
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incubation because the cultivation volume is relatively small (<50mL working volume) and thus 1 
the product concentration may be condensed (e.g., 10~20% water loss was normally observed 2 
after three-day shaking flask cultivations at 37 oC). In all these circumstances, the final product 3 
yield could be very different from the intrinsic microbial product yield. To obtain the true 4 
productivity, in situ product recovery is a common method to reduce product loss. For example, 5 
volatile alcohol products can be trapped in organic solvents during microbial fermentation (e.g., 6 
gas striping) 130, 136, 137. Alternatively, kinetic model can be used to obtain intrinsic product yields 7 
via parameter estimation based on complete time-course fermentation data and statistical 8 
analysis (to avoid local solutions) 129.  Thirdly, 13C-experiments can also resolve artifacts during 9 
measurement of intrinsic product yields. By addition of small amount of 13C-product in the 10 
culture as an internal standard, we can directly measure the change of 13C-product during 11 
fermentation (Figure 3.3).  Then, 13C-data from time points can be used to correct the artifact of 12 
yield coefficients: 
*
1 *
dC k C
dt
= − ,  where C
* represents the 13C concentration of the product and 13 
k1 is assumed the first order constant for product loss. Thereby, 
*
2
1 2 1*
1
ln( ) / ( )t
t
Ck t t
C
= − − . By 14 
analyzing the change in 13C concentration at two different time points (t1 and t2), k1 can be 15 
calculated. The product loss term can be added to the normally measured product curves for 16 
correction of intrinsic product curves.  17 
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 1 
Figure 3.3: Schematic showing the dynamics of product concentration. Ca is the actual 2 
concentration and Cm is the measured product concentration. C* indicates the concentration of 3 
the 13C product added as an internal standard. 4 
 5 
3.5 Assessment of maximum product yield  6 
  7 
Theoretical product yield is generally calculated based on the stoichiometry of product 8 
synthesis from a carbon substrate (without accounting both biomass growth and waste secretion). 9 
However, microbial energy metabolism may also be affecting product yield which is seldom 10 
accounted. The synthesis of high-energy chemicals often requires large amounts of ATPs, while 11 
cell maintenance (used for regeneration of degraded macromolecules, futile cycles, and ATP 12 
leaks) also competes for the same ATPs 138. Oxidative phosphorylation of NADH is a major 13 
source for ATP generation (theoretical P/O ratio: 1 NADH  3 ATPs) 139. However, respiration 14 
efficiency in engineered strains could be poor (e.g., the P/O ratio = 1.3 during riboflavin 15 
fermentation 140) due to metabolic stresses 141. Thereby, a cell may consume extra substrates to 16 
compensate for the ATP demand. To illustrate the effect of cell maintenance on product yield 142, 17 
a flux balance model was built to show free fatty acid production as a function of ATP 18 
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maintenance and P/O ratios (Figure 3.4) 143. This model employs eight reactions (Table 3.1) and 1 
the fluxes were resolved by the function below: 2 
[ max (2)
such that A  and  
v
v b lb v ub⋅ = ≤ ≤
], 3 
where the objective function is to maximize v(2) (i.e., the relative flux of fatty acid). A is the 4 
reaction stoichiometry. lb and ub are upper and lower bound for each reaction flux, v(i).  Fig. 5 
3.4a shows the relationship between maximum yield, P/O ratio and ATP maintenance without 6 
biomass growth (v(8)=0). A Higher P/O ratio makes the microbial system less sensitive to the 7 
increased demand for ATP. When the ATP maintenance is low and the P/O ratio is close to 3, the 8 
fatty acid yield can reach the theoretical value of 0.36g fatty acid/g glucose. In this case, 9 
reduction of carbon loss via knock-out of competitive pathways will be effective to achieve the 10 
theoretical yield (Figure 3.4A). If ATP consumption for maintenance increases, cells need to 11 
“burn” extra carbon substrates for energy generation so that fatty acid yields drop significantly. 12 
In this case, the biosynthesis optimization needs to reduce the loss of ATP/NADH. For example, 13 
in a study of the engineered E.coli metabolism responding to fatty acid overproduction 143, 13C-14 
MFA (via extensive flux calculation) found that the total ATP/NAD(P)H generation was much 15 
higher than their consumption for biomass growth and fatty acid synthesis. Such difference was 16 
attributed to the low P/O ratio and high cell maintenance during fatty acid overproduction. 17 
Therefore, the engineered strain had a fatty acid yield of only 0.17g fatty acid/g glucose even 18 
after extensive pathway engineering, (Figure 3.4B). The suboptimal energy metabolism in the 19 
engineered strain was likely due to the various physiological stresses experienced by the cell 20 
during fatty acid overproduction (e.g., change cell membrane integrity and compositions 144). 21 
Since metabolic stresses are commonly experienced by microbial hosts, 13C-MFA can provide a 22 
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diagnostic analysis of cell maintenance and offer insights into the metabolic potential for 1 
improving biosynthesis 145.  2 
 3 
Table 3.1: Simplified biochemical reactions considered in the model 4 
 5 
Flux, v Reactions Note 
v(1) Glucose  2AceCoA + 2ATP + 4NADH Glycolysis 
v(2) AceCoA + 1.75NADPH + 0.875ATP  0.125 C16:0 fatty acid Fatty acid synthesis 
v(3) AceCoA  2NADH + NADPH + ATP + FADH2 TCA cycle 
v(4) NADH  NADPH Transhydrogenation 
v(5) NADH  P/O ATP Oxidative phosphorylation 
v(6) FADH2  0.67(P/O)ATP Oxidative phosphorylation 
v(7) ATP ATP_ext ATP maintenance 
v(8) 6.6Glucose + 37.6ATP + 9.5NADPH + 2.5AceCoA= 39.7Biomass + 3.1NADH Biomass formation 
Note: glucose consumption for both biomass growth and product synthesis is normalized to 100. 6 
The optimization was performed by a linear optimizer ‘linprog’ in MATLAB. The final yield (g 7 
fatty acid/g glucose) is calculated as follows: Y=(v(2)/8∙256)/(100∙180) g C16:0 fatty acid/g 8 
glucose.9 
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(A)                                (B) 
 
Figure 3.4: (A) Theoretical Yield as a function of P/O ratio and ATP maintenance without 
biomass growth. (B) Theoretical Yield as a function of P/O ratio and ATP maintenance at growth 
rate v(8)=3.6. The units of yield and ATP maintenance are ‘g C16:0 fatty acid/g glucose’ and 
‘mol ATP /g glucose’ respectively. The infeasible range in the surface plot indicates that, energy 
cannot be balanced for fatty acid or biomass production in that region, resulting in zero yield 143. 
 
3.6 Product yield from unconventional engineered pathway 
 
         13C-analysis can be used to decipher the yield of products through multiple biosynthesis 
routes. For example, the acetogenic bacterium Clostridium carboxidivorans uses syngas (H2, CO 
and CO2) to generate various chemicals (e.g., acetate, ethanol, butanol, and butyrate) 146.  It 
contains several routes for CO2 fixation, which includes the Wood-Ljungdahl pathway and the 
anaplerotic or the pyruvate synthase reactions. 13C-experiments can be used to identify the 
relative contribution of the different CO2 fixation pathways towards product synthesis. As a 
demonstration, cultivation of Clostridium with labeled 13CO2 and 12CO has been shown in Fig. 
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3.5. Here, 13C-analysis of the labeling patterns in either alanine or pyruvate can reveal the 
relative contributions of the different CO2 assimilation routes to biomass and product synthesis.   
 
 
Figure 3.5: 13C analysis to study the carbon assimilation during syngas fermentation (13CO2, 
12CO and H2). Analysis of metabolite labeling patterns can determine CO2 and CO utilization for 
pyruvate production. The isotopomer data of pyruvate were used as a demonstration of 13C 
applications for product yield calculations. 
 
 “Rule of Thumb” indicates that 20%~30% yield reduction happens per engineered 
enzymatic reaction step 63, 128. Thereby, novel pathways are constantly being explored and 
engineered into microbial hosts to create a short-cut route from the feedstock to the final product. 
If new pathways are engineered into microbes, it could be unclear how much the engineered 
pathways are used by the microbe in parallel with its original pathway 147. In the following 
example, we demonstrate that 13C-experiments can determine the relative fluxes through multiple 
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pathways based on measurements of the product labeling. Specifically, butanol could be   
 
Figure 3.6: Threonine and citramalate pathway for the synthesis of 1-butanol.  The carbon 
rearrangement network shows the labeling of 1-butanol for both the pathways, when fed with 1-
13C pyruvate and 13C bicarbonate. 
 
produced simultaneously from a threonine pathway and a citramalate pathway (a short-cut keto 
acid-mediated pathway) in E.coli 148. If 1st position 13C-pyruvate and 13C-bicarbonate are fed to 
the butanol producing strain, labeling patterns in butanol can quantify fluxes through the two 
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biosynthesis pathways (Fig. 3.6). In another example, James Liao Lab introduced a non-
oxidative glycolytic cycle (NOG) into E.coli for breaking down hexose that could lead to a 50% 
increase of biofuel yield 117. This NOG pathway starts with fructose 6-phosphate and contains 
three metabolic cycles to generate Acetyl-CoA without carbon loss. To probe the contribution of 
NOG pathway to overall cell metabolism, their study has also presented a carbon rearrangement 
map so that 13C-tools can be employed. These examples illustrates that 13C-analysis is potentially 
suited to examine in vivo activity of these novel pathways for product synthesis. 
3.7 Conclusion 
 
           Product yield is one of the main factors involved in commercialization of a 
technology 149. Microbial productivity is not only associated with the efficiency of biosynthesis 
enzymes, but is also intertwined with energy metabolisms and metabolic balances 150. Via simple 
13C analysis, we can characterize the hosts’ intrinsic production yield using different carbon 
sources, and determine the contributions of alternative pathways to biosynthesis. In addition, 
13C-MFA can profile hosts’ fluxomes and determine the amount of extra substrates that cell 
metabolism has to consume to compensate ATP losses due to cell maintenance and low P/O 
ratio. In the end, loss of products during fermentations (such as volatile alcohols or product 
degradation) introduces common measurement errors and artifacts 130, 136, 137. The accurate 
quantification of unstable metabolites can also be achieved via 13C-based method (i.e., using 
isotopomer labeled internal standards) 151.  Through this review paper, we hope that the 
metabolic engineering field will recognize more value of 13C-techniques and foresee an extended 
use of 13C-experiments during the development of microbial cell factories.  
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Chapter 4: Metabolic engineering of Synechocystis 
6803 for isobutanol production 
This chapter has been reproduced from the following publication: 
Varman, A.M., Xiao, Y., Pakrasi, H.B. & Tang, Y.J. Metabolic Engineering of Synechocystis sp. 
Strain PCC 6803 for Isobutanol Production. Applied and Environmental Microbiology 79, 908-
914 (2013). 
 
Abstract 
     Global warming and decreasing fossil fuel reserves have prompted great interest in the 
synthesis of advanced biofuels from renewable resources. In an effort to address these concerns, 
we have performed metabolic engineering of the cyanobacterium Synechocystis sp. PCC 6803 to 
develop a strain that can synthesize isobutanol under both autotrophic and mixotrophic 
conditions.  With the expression of two heterologous genes from the Ehrlich Pathway, the 
engineered strain can accumulate 90 mg/L of isobutanol from 50 mM bicarbonate in a gas-tight 
shaking flask. This strain does not require any inducer (i.e., IPTG: Isopropyl β-D-1-
thiogalactopyranoside) or antibiotics to maintain its isobutanol production. In the presence of 
glucose, isobutanol synthesis is only moderately promoted (titer = 114 mg/L). Based on 
isotopomer analysis, we find that compared to the wild-type strain, the mutant significantly 
reduced its glucose utilization and mainly employed autotrophic metabolism for biomass growth 
and isobutanol production. Since isobutanol is toxic to the cells and may also be degraded 
photochemically by hydroxyl radicals during the cultivation process, we employed in situ 
removal of the isobutanol using oleyl alcohol as a solvent trap. This resulted in a final net 
concentration of 298 mg/L of isobutanol under mixotrophic culture conditions. 
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4.1 Introduction 
 
           Global energy needs continue to increase rapidly due to industrial and development 
demands, furthering environmental concerns.  Much of the worldwide energy consumption 
comes from the burning of fossil fuels, which produces  about 6 gigatons of CO2 annually 152.  
Increasing CO2 levels may act as a feedback loop to increase the soil emissions of other 
greenhouse gases such as methane and nitrous oxide, heightening global temperature 153.  For 
energy security and environmental concerns, there is an urgent demand for the development of 
bioenergy. Bioethanol is the most common biofuel, but it also has low energy density and 
absorbs moisture.  Isobutanol (IB) is a better fuel because it is less water soluble and has an 
energy density / octane value close to that of gasoline 154, 155.  Amongst the next generation 
biofuels synthesized from pyruvate, IB possesses fewer reaction steps (5 reaction steps from 
pyruvate to IB) in contrast to the synthesis of 1-butanol or biodiesel. IB is less toxic to microbes 
25 so that it may achieve higher product titer and yield 63, 128. For example, a maximum titer of 
50.8 g/L of IB can be achieved in an engineered E. coli 130.  
On the other hand, cyanobacteria can not only convert CO2 into bio-products, but also 
can play an important role in environmental bioremediations. The photosynthetic efficiency of 
cyanobacteria (3~9%) is high compared to higher plants (≤0.25~3%) 1, 13.  Furthermore, some 
species of cyanobacteria are amenable to genetic engineering.  Table 4.1 lists the various biofuels 
that have been synthesized through the metabolic engineering of cyanobacteria. Autotrophic IB 
production in cyanobacteria was first demonstrated in Synechococcus 7942 28.   Moreover, a 
model cyanobacterium Synechocystis sp. PCC 6803 is capable of growing under both 
photoautotrophic and mixotrophic conditions, while the presence of glucose can significantly 
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promote biomass and bioproduct synthesis 156. Thereby, we have engineered a glucose tolerant 
Synechocystis 6803 strain with two key genes kivd and adhA of the Ehrlich pathway26  so that the 
cyanobacterial strain can convert CO2 into IB. Through both metabolic engineering and 
bioprocess optimization, we have improved our strain’s IB production capabilities. 
4.2 Materials and methods 
 
4.2.1 Chemicals and reagents.  
           Restriction enzymes, T4 DNA ligase, DNase and a Revertaid first strand cDNA synthesis 
kit were purchased from Fermentas or New England Biolabs.  Oligonucleotides were purchased 
from Integrated DNA Technologies. Toluene, IB, α-ketoisovaleric acid, phenol and chloroform 
were purchased from Sigma-Aldrich (St. Louis, MO). KlenTaq-LA 157 was purchased from DNA 
Polymerase Technology (St. Louis, MO). TRI Reagent® was purchased from Ambion, USA. 13C 
labeled glucose was purchased from Cambridge Isotope Laboratories. 
4.2.2 Culture medium and growth conditions.  
           A glucose tolerant wild-type strain of Synechocystis 6803 (WT) and the recombinant 
strain AV03 were grown at 30°C in liquid BG-11 medium or solid BG-11 medium at a light 
intensity of 50 µmol of photons m-2s-1 in ambient air.  Kanamycin at a concentration of 20 
µg/mL was added to the BG-11 medium when required. Growth of the cells was monitored by 
measuring OD730 of the cultures on an Agilent Cary 60 UV-Vis Spectrophotometer. Cultures for 
the synthesis of IB were grown in 10 mL medium (Initial OD730 of 0.4) in 50 mL shake flasks for 
4 days.  The mid-log phase cultures were then closed with rubber caps to prevent the loss of IB 
during incubation, and the cultures were supplemented with 50 mM NaHCO3 as an inorganic 
carbon source.  Mixotrophic cultures of Synechocystis 6803 were started in a BG-11 medium 
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containing a known amount of glucose as an organic carbon source.  E. coli strain DH10B was 
the host for all plasmids constructed in this study.  E. coli cells were grown in falcon tubes 
containing Luria-Bertani (LB) medium at 37°C under continuous shaking. Ampicillin (100 
µg/mL) or kanamycin (50 µg/mL) was added to the LB medium when required, for the 
propagation of plasmids in E. coli.  
4.2.3 Plasmid construction and transformation of Synechocystis 6803. 
              
           The vector pTAC-KA containing an ampicillin resistance cassette (AmpR) and two genes 
(kivd and adhA from Lactococcus lactis) was constructed as described 129. The pTAC-KA vector 
was modified using the following steps to convert it into a Synechocystis 6803 vector. To clone 
the flanking regions of a potential neutral site into pTAC-KA, a Synechocystis 6803 vector 
pSL2035 containing both the flanking regions and the kanamycin resistance cassette (KmR) was 
used as a template. pSL2035 is a Synechocystis 6803 vector designed to integrate any foreign 
DNA into the genome of Synechocystis 6803 by replacing the psbA1 gene and its promoter.  
psbA1 is a member of psbA gene family and is found to be silent under most conditions 158, 159.  
pSL2035 was constructed by cloning the flanking regions for the psbA1 gene and the KmR into 
pUC118. The 5’ flanking region from pSL2035 was PCR amplified along with KmR by 
respective primers (Table 4.2) and cloned into the PciI and Bsu36I site of pTAC-KA, resulting in 
the vector pTKA2.  The 3’ flanking region was PCR amplified from pSL2035 by the respective 
primers and inserted into the AhdI site of pTKA2, disrupting the native AmpR and henceforth 
creating the vector pTKA3. 
Transformation was performed by using a double homologous recombination system, and 
the genes were integrated into the target site of the Synechocystis genomic DNA. Specifically, 2 
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mL of Synechocystis 6803 from a mid-log phase (1~3×108 cells mL-1) culture was centrifuged at 
10,000 × g for 2 min. The pellet was suspended in a fresh BG-11 medium (200 µL) to a final cell 
density of 1~3×109 cells mL-1. Plasmid DNA was added to a final DNA concentration of 5~10 
µg/mL 19 to this dense Synechocystis 6803 cell culture. The mixture was then incubated under 
normal light conditions (50 µE m-2 s-1) overnight. The culture was then spread onto a BG-11 agar 
plate containing 20 µg/mL of kanamycin. Recombinant colonies usually appear between 7 and 
10 days. Colonies were propagated on a fresh BG-11 plate containing kanamycin, and a colony 
PCR was performed to verify successful integration of the insert into the genomic DNA of the 
recombinant. The positive colonies were propagated continuously onto BG-11 plates containing 
kanamycin, to get a high segregation of the insert in the recombinant 17. To verify the integrity of 
the promoter and gene sequences, the heterologous DNA integrated into the genome of the 
mutant AV03 was PCR amplified and sent for sequencing with the respective primers.   
4.2.4 Reverse transcription PCR (RT-PCR).  
           Total RNA isolation of Synechocystis 6803 was performed using a TRI Reagent® 
(Ambion, USA) by following the manufacturer protocol with modifications. 1 mL of RNAwiz 
was prewarmed to 70°C and pipetted into the frozen cells directly. Immediately, the mixture was 
vortexed and incubated for 10 min at 70°C in a heater block. 0.2 mL of chloroform was added to 
the mixture and mixed vigorously followed by incubation at room temperature for 10 min. The 
aqueous and the organic phase were separated by centrifugation at 10,000 × g at 4°C.  The RNA 
containing aqueous phase was transferred into an eppendorf tube, to which, equal volumes of 
phenol and chloroform were added. The mixture was mixed vigorously followed by 
centrifugation to separate the aqueous and the organic phase. The aqueous phase was removed to 
a clean tube, to which 0.5 mL of diethyl pyrocarbonate (DEPC) treated water was added.  RNA 
60 
 
 
in the solution was precipitated by the addition of room temperature isopropanol and centrifuged 
at 10,000 × g at 4°C to pellet the RNA.  The RNA was washed with ethanol and resuspended in a 
fresh 50 µL of DEPC treated water.  The quantity and quality of the isolated RNA was 
determined using a Nanodrop ND-1000 (Thermo Scientific, USA).  The RNA was incubated at 
room temperature with DNase to degrade any genomic DNA, if present in the RNA sample. 
Synthesis of cDNA was performed by utilizing a Reverse transcriptase enzyme from Fermentas 
along with dNTPs and random primers in a reaction buffer.  The mixture was incubated at 42°C 
for 60 min.  The synthesized cDNA was used as a template for the PCR, to detect the expression 
of the mRNA of interest. 
4.2.5 Isobutanol quantification assay.  
           IB synthesized in the culture was quantified using a gas chromatograph (Hewlett Packard 
model 7890A, Agilent Technologies, equipped with a DB5-MS column, J&W Scientific) and a 
mass spectrometer (5975C, Agilent Technologies). IB extraction was done using a modified 
procedure 118.  Samples of the cyanobacterial culture (400 µL) were collected and centrifuged at 
10000 × g for 5 min. IB was extracted from the supernatant by vortexing for 1 min with 400 µL 
of toluene, and methanol was used as the internal standard.  A 1 µL sample of the organic layer 
was injected into the gas chromotagraph (GC) with helium as the carrier gas. The GC oven was 
held at 70°C for 2 min and then raised to 200°C with a temperature ramp of 30°C min-1, and the 
post run was set at 300°C for 6 min. The range of the mass spectrometer (MS) scan mode was set 
between m/z of 20 and 200. The concentration of IB present in the culture was determined based 
on a calibration curve prepared with known concentrations of IB ranging from 25 mg/L to 400 
mg/L. 
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4.2.6 13C-experiment to detect carbon contribution of glucose.  
           The 13C-abundance of some important metabolites was measured for both the wild-type 
and the mutant strain AV03, to estimate the carbon contribution of both glucose (fully labeled by 
13C) and nonlabeled bicarbonate for biomass and IB synthesis. Mixotrophic cultures of both the 
wild-type Synechocystis 6803 and the mutant AV03 were grown in BG-11 medium (with 50mM 
nonlabeled NaHCO3), which contained 0.5% glucose (U-13C, Cambridge Isotope Laboratories, 
MA).  Cultures were collected on day 3, 6 and 9, and proteinogenic amino acids were hydrolyzed 
and then derivatized with TBDMS (N-(tert-butyldimethylsilyl)-N-methyl-trifluoroacetamide, 
Sigma-Aldrich). The derivatized amino acids were analyzed for their mass isotopomer 
abundance by GC-MS, as described before 160, 161. The m/z ion [M-57]+, which corresponds to 
the entire amino acid, was used to calculate the 13C abundance in amino acids [m0 m1…. mn].  
The fraction of carbon (FA) derived from fully labeled glucose for each amino acid was estimated 
based on the following equation:  
n
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n
i i
A
∑ = ×= 1                  (4.1)   
where i is the number of labeled carbons, mi is the mass fraction for different isotopomers of the 
corresponding amino acid and n represents the total number of carbons in the corresponding 
amino acid. The m/z of [M-15]+ was used only for leucine and isoleucine, since their [M-57]+  
overlaps with other mass peaks 162. IB extraction was performed for samples obtained from the 
above cultures and was analyzed using the GC-MS. The fraction of carbon derived from glucose 
for isobutanol (FIB) was estimated based on the isobutanol MS peak abundances:  
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where Ai is the abundance of the mass-to-charge ratio peaks for the various isobutanol 
isotopomers (i.e., A0~A4 for m/z=74~78). 
4.3 Results  
 
4.3.1 Construction of an isobutanol producing Synechocystis 6803 strain.  
           IB synthesis in Synechocystis 6803 requires the expression of two heterologous genes of 
the Ehrlich pathway.  The enzymes 2-keto-acid decarboxylase and alcohol dehydrogenase can 
convert 2-keto acids into alcohols. In this work, we constructed a plasmid pTKA3 containing the 
genes kivd and adhA from Lactococcus lactis under the control of an IPTG inducible promoter, 
Ptac. The plasmid was designed to integrate the genes into a neutral site in the genome of 
Synechocystis 6803, along with a kanamycin resistance cassette (Fig. 4.1a - Left).  The wild-type 
strain of Synechocystis 6803 was transformed with pTKA3, resulting in the recombinant strain 
AV03.  The integration of the insert genes into the genome was verified by a colony PCR after 
several rounds of segregation (Fig. 4.1a - Right).   
 To identify the optimal IPTG concentration required for IB synthesis, the AV03 strain 
was grown under different concentrations of IPTG.  IB analysis from the cultures indicated that 
IB was highly synthesized even without the addition of IPTG (Fig. 4.1b). To verify if this 
observation was an artifact of any mutations that might have occurred in lacI or the promoter, the 
foreign DNA integrated into the chromosome of AV03 was sequenced. Sequencing results for 
the lacI and the promoter Ptac in the genome of AV03 revealed that the nucleotide sequence was 
completely intact. There have been reports of leaky expressions with IPTG inducible promoters 
163. Besides, Fig. 4.1b indicates that as the concentration of IPTG went higher than 1mM, the IB 
synthesis reduced.  The OD730 of the different cultures indicated that the addition of IPTG did 
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not apparently interfere with the growth rate of the culture. RT-PCR showed the expression 
levels of the genes kivd and adhA under different IPTG concentrations. The result of RT-PCR 
experiment (Fig. 4.1b - Inset) indicated that the levels of kivd and adhA mRNA synthesized in 
the mutant were higher with IPTG than without. Henceforth, lower expression of the two genes 
is sufficient for IB synthesis, possibly because the Ehrlich pathway may not be the rate-limiting 
step for IB production. 
4.3.2 Isobutanol synthesis under autotrophic and mixotrophic growth.  
           Under autotrophic conditions, Synechocystis 6803 utilizes light as an energy source (ATP 
and NADPH) for the conversion of CO2 into biomass and IB. Fig. 4.2a compares the autotrophic 
growth of the mutant and the wild strain. Under autotrophic conditions, we found that the growth 
rate of the mutant AV03 remains unaltered as compared to the wild-type strain.  IB accumulation 
in the mutant was tested under autotrophic condition (Fig. 4.2b), and the strain was found to 
synthesize a maximum of 90 mg/L of IB (the only extracellular product detected by GC-MS) in a 
6-day culture. In a sealed shaking flask, NaHCO3 in the medium (50mM) was consumed by 
AV03 within six days, and then both the biomass and IB started declining.  
The wild-type strain of Synechocystis 6803 grows about 5 times faster under mixotrophic 
conditions compared to autotrophic conditions (Fig. 4.2a).  However, our mutant AV03 did not 
exhibit an increased growth rate under mixotrophic conditions. To measure the glucose 
utilization by wild-type and mutant AV03, we fed cells with 0.5% fully labeled glucose and 
nonlabeled bicarbonate. Isotopomer analysis of 13C-abundance in cell metabolites (Fig. 4.2c) 
showed that the wild-type synthesized 70~90% of its amino acids using carbons from glucose, 
whereas the mutant produced biomass only using 5~10% carbon from glucose, and 12% of the 
carbon of IB was labeled (i.e., derived from glucose). These results indicated that the mutant 
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tended to limit glucose metabolism for IB production. The AV03 strain was found to synthesize 
a maximum of 114 mg/L of IB mixotrophically after 9 days (Fig. 4.2b), whereas cells with only 
glucose (heterotrophic without bicarbonate or CO2) synthesized a maximum of 27 mg/L of IB.  
This result suggests that the Synechocystis 6803 mutant is unable to take significant advantage of 
its glucose metabolism to have a fast rate of IB production.  
4.3.3 In situ alcohol concentrating system using a solvent trap.   
           IB is toxic to the cells and our study revealed that IB inhibited Synechocystis 6803 growth 
at external concentrations of only 2 g/L (Fig. 4.3). Moreover, our control experiments indicated 
the loss of IB after 9 days of continuous incubation. IB can be slowly degraded by photo-
chemically-produced hydroxyl radicals in aerobic cyanobacterial cultures 164-166. Therefore, a 
system with continuous removal of the synthesized alcohol products will be beneficial 167, 168. We 
have demonstrated the use of an in situ alcohol removal system by using oleyl alcohol 169, 170 as a 
solvent trap for increasing IB titer. In previous studies, gas stripping is one efficient way for IB 
recovery, but it requires an expensive cooling system due to very low concentrations of IB from 
photo-bioreactors. Here, inside each cultivation flask, we placed a small glass vial containing 0.5 
or 1 mL oleyl alcohol solvent, so that oleyl alcohol was not mixed with the culture solution (Fig. 
4.4).  Volatile IB in the headspace can be trapped in the solvent vial because of the high 
solubility of IB in oleyl alcohol. This method will effectively trap the IB while the solvent will 
not directly interfere with light and cell culture conditions.  
 To test the effect of oleyl alcohol on IB productivity, we did a 3-week time-course study 
(Fig. 4.4) by adding 50 mM NaHCO3 intermittently (every 4 days).  During the cultivation, the 
pH of the cultures was also adjusted to be between 8 and 9 before the addition of excess 
bicarbonate. Every 3 days, the oleyl alcohol in the vials was taken out for IB measurement, and 
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then replaced with fresh oleyl alcohol. The mixotrophic cultures with alcohol trap (0.5 mL) 
reached the highest net IB concentration of 298 mg/L.  The autotrophic cultures with 0.5 mL and 
1 mL oleyl alcohol had a maximum net IB titer of 180 mg/L and 240 mg/L, respectively, 
whereas the autotrophic cultures without the oleyl alcohol trap were able to achieve a maximum 
of only 108 mg/L of IB.  IB levels in the organic phase reached concentrations of up to 500 mg/L 
with only 3 days of trapping. 
4.4 Discussion 
 
Isobutanol (IB) is a promising biofuel for the replacement of gasoline. So far, E. coli has 
remained the most successful microbial host for IB production. In this study, we have focused 
our efforts on a cyanobacterial species, Synechocystis 6803, which can grow on both CO2 and 
glucose. The mixotrophic cultivation may offer industrial flexibility and economic benefits 
because the gas-liquid mass transfer of CO2 is often a rate-limiting step in efficient 
photobioreactor operations.  Attempts in creating a stable strain of Synechococcus 7942 that can 
transport and utilize glucose has been barely successful 171. The glucose tolerant strain of 
Synechocystis 6803 unlike other cyanobacterial strains, can perform both autotrophic and 
mixotrophic metabolisms.  In our work, we found that the wild-type strain of Synechocystis 6803 
under mixotrophic conditions grew at a rate 5 times faster than the autotrophic condition. 
Moreover, the engineered Synechocystis 6803 strain accumulated 90 mg/L of IB, whereas the 
Synechococcus 7942 strain expressing the same two enzymes (keto-acid decarboxylase and 
alcohol dehydrogenase) only accumulated a maximum of 18 mg/L 28. Switching the condition 
from autotrophic to mixotrophic for the mutant AV03 increased the maximum IB titer to 114 
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mg/L. Interestingly, the mutant tended to grow autotrophically and had minimal glucose 
utilization compared to the wild-type strain (Fig 4.2c).  
IB can be inhibitory to cell physiologies. Moreover, our experiments also observed IB 
degradation (by hydroxyl radicals) during the incubation process. Thereby, efforts in coming up 
with product recovery are important to improve IB titer in cyanobacterial culture.  This work 
employed an in situ IB removal system by growing cultures in shake flasks with vials containing 
oleyl alcohol. Mixotrophic growth of AV03 along with in situ IB removal synthesized a 
maximum of 298 mg/L IB, which is lower than the highest IB titer (450 mg/L) reported in 
Synechococcus 7942 mutant expressing 3 more genes of the keto acid pathway. On the other 
hand, our strain design has two apparent advantages for industrial application. First, our strain 
does not require any antibiotics to maintain its IB production because the two heterologous genes 
in the mutant show good stability during normal cultivation conditions. Second, the strain does 
not need any inducer (IPTG) for IB production, which can significantly reduce the industrial 
costs. 
Overexpressing the keto acid pathway can increase the IB titer in Synechococcus 7942 28. 
Furthermore, optimizing CO2 and light conditions of the cyanobacterial strain can also increase 
the final titer and productivity. Liu et. al., 172 have reported a doubling time of 7.4 hours for 
Synechocystis 6803, by growing them under 140 µmol of photons m-2 s-1  of light and by 
bubbling 1% CO2 enriched air. Therefore, our strain can serve as a springboard for future 
development of higher performance Synechocystis 6803 strains with increased IB titer and 
productivity. 
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In summary, IB synthesis under autotrophic conditions in a cyanobacterium 
Synechocystis 6803 was demonstrated by the expression of two heterologous genes.  It was 
further demonstrated that mixotrophic cultures of the mutant can significantly increase IB 
synthesis with minimal glucose consumption. The mechanism behind the reduced glucose-
utilizing metabolism of AV03 compared to the wild-type strain remains unclear. A possible 
explanation is that the cells tend to avoid the intracellular metabolic imbalance or IB 
intermediate inhibition by down-regulating glucose uptake. Using oleyl alcohol as a simple 
solvent trap, IB production can be improved by 2~3 times.  Therefore, in situ IB recovery may 
reduce the product loss and separation cost. We have also demonstrated that a simple expression 
of the Ehrlich pathway with bioprocess modification can synthesize IB without other major 
waste products, while still achieving comparable levels of IB to an extensive genetically 
modified Synechococcus 7942 strain (Table 4.1) 28. 
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Figure 4.1a 
 
 
Figure 4.1b 
 
Figure 4.1:  (a) Schematic representation to show the integration of the genes kivd and adhA 
into the genome of Synechocystis 6803. Colony PCR performed to verify the integration of the 
insert into the genomic DNA of the mutant (AV03).  The vector ptka3 w was used as a template 
   1         2         3          4     
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for the positive control and wild-type cells were used as negative control.  Colony PCR of AV03, 
showed the presence of a band (8.3kb) the same size as the positive control (+ve) and the 
absence of the negative control (WT) band. (b) IB synthesized by engineered Synechocystis 6803 
under different IPTG concentrations (n=3). (Inset) Result of an RT-PCR performed to detect the 
expression of the heterologous genes kivd (Top: 500bp from kivd) and adhA (Bottom: 200bp 
from adhA).  Lane 1, wild-type 6803 (WT); Lane 2, AV03 with 0 mM IPTG;  Lane 3, AV03 
with 0.5mM IPTG; Lane 4, AV03 with 1mM IPTG.  
 
                                                                                                                                                                                                 
 
Figure4. 2a 
 
 
 
Figure4. 2b 
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Figure 4.2c 
 
Figure 4.2:  (a) Growth curves of Synechocystis 6803 WT and AV03 (n=3, shake flask cultures): 
◊ WT under autotrophic, ♦ WT under mixotrophic, ○ AV03 under autotrophic and ● AV03 
under mixotrophic conditions (note: growth curve of AV03 under mixotrophic condition 
overlaps with autotrophic growth curves of AV03 and WT). (b) IB synthesized in AV03 under 
autotrophic conditions (only HCO3), heterotrophic (only glucose) and mixotrophic (both HCO3 
and glucose) conditions (n=3, shake flask cultures with closed caps).  (c) Percentage carbon 
contribution of glucose for synthesizing amino acids and isobutanol in the wild-type (WT) and 
the mutant strain (AV03) as measured on day 9 (shake flask cultures with closed caps).  
Isotopomer analysis (TBDMS based method) of proteinogenic amino acids confirms the low 13C-
glucose utilization by the mutant.  The error bar represents the 2% technical error of the 
instrument. 
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Figure 4.3 
 
 
Figure 4.3:  Toxic effects of IB on the growth of Synechocystis 6803.  IB was added to a final 
concentration (g/L, n=2) of ◊ 0, □ 0.2, Δ 0.5, ○ 1, ■ 2 and ● 5 to a Synechocystis 6803 culture 
with an initial OD730 ~ 0.8. 
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Figure 4.4 
 
Figure 4.4:  Net concentration of IB synthesized (columns) and biomass growth (curves) by the 
AV03 culture under different conditions (n=3). a – IB with 0.5 mL oleyl alcohol (Autotrophic); b 
– IB with 1 mL oleyl alcohol (Autotrophic); c – IB with 0.5 mL oleyl alcohol and glucose 
(Mixotrophic); d – IB with no oleyl alcohol (Autotrophic, negative control); a1 – OD730 with 0.5 
mL oleyl alcohol (Autotrophic); a2 – OD730 with 1 mL oleyl alcohol (Autotrophic);  a3 – OD730 
with 0.5 mL oleyl alcohol and glucose (Mixotrophic); a4 – OD730 with no oleyl alcohol 
(Autotrophic, negative control). (Inset) Schematic representation of the in situ IB removal 
system used to increase the production of IB.  
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Table 4.1:  Metabolic engineering of cyanobacterial strains for biofuel production. 
Product Species Titer or 
Productivity 
Overexpressed 
genes 
Promoters Culture vessel / Remarks Culture 
Days 
Ref. 
Ethanol Synechococcus 
7942 
230 mg/L pdc and adh 
 
rbcLS Shake flask 28 days 173 
Ethanol Synechocystis 
6803 
552 mg/L pdc and adh 
 
psbA2 Photobioreactor 6 days 21 
Isobutyrald
ehyde 
Synechococcus 
7942 
1100 mg/L alsS, ilvC, ilvD, kivd 
and rbcls  
LlacO1 , trc and 
tac 
Roux culture bottle with 
NaHCO3 
8 days 28 
Isobutanol Synechococcus 
7942 
18 mg/L kivd and yqhD 
 
trc Shake flask with NaHCO3 1 day 28 
Isobutanol Synechococcus 
7942 
450 mg/L alsS, ilvC, ilvD, kivd 
and yqhD  
LlacO1 , trc Shake flask with NaHCO3 6 days 28 
Fatty 
alcohol 
Synechocystis 
6803 
200±8 µg/L far  rbc Photobioreactor with 5% CO2 18 days 30 
Alkanes Synechocystis 
6803 
162±10 
µg/OD/L 
accBCDA  rbcl Shake flask - 30 
Fatty acids Synechocystis 
6803 
197 ±14 mg∕L tesA, accBCDA, 
fatB1, fatB2, tesA137  
psbA2, cpc, and 
trc 
1% CO2 bubbling  17 days 172 
Hydrogen Synechococcus 
7942 
2.8 
µmol/hr/mg 
Chl-a* 
hydEF, hydG and 
hydA  
psbA1, lac Anaerobic conditions with 
DCMU treatment** 
- 32 
1-Butanol Synechococcus 
7942 
14.5 mg/L hbd, crt, adhE2, ter 
and atoB  
trc, LlacO1 Dark roux culture bottle under 
anoxic condition 
7 days 29 
Fatty 
alcohol 
Synechocystis 
6803 
20 ± 2  
µg/L/OD 
far, aas  rbc, psbA2 Shake flask - 174 
1-Butanol Synechococcus 
7942 
30 mg/L ter, nphT7, bldh, 
yqhD, phaJ, phaB  
trc, LlacO1 Shake flask 18 days 175 
 
where *Chl-a is chlorophyll a; **DCMU is 3-(3,4-dichlorophenyl)-1,1-dimethylurea. 
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Table 4.2:  Primer sequences used in this study. 
Name Sequence (5’→3’) 
AMV14F GCGCACATGTCGGAACAGGACCAAGCCTTGAT 
AMV15R GCGC CCTGAGGCCTTTACCATGACCTGCAGGG   
AMV16F GCGCGACGGGGAGTCAATTGTGCCATTGCCATAACTGCTTTCG 
AMV17R GCGCGACTCCCCGTCTTTGACTATCCTTTTTAGGATGGGGCA 
ps1_up_fwd
 
TACCGGAACAGGACCAAGCCTT   
AMV01 GCGCCATATGTATACAGTAGGAGATTACCTATTAGAC    
AMV12 GCAGCAGCAACATCAACTGGTAAG 
AdhA-TMs TCAACTAGTGGTACCAGGAGATATAATATGAAAGCAGCAGTAGTAAG
  
adhA_RTr GACAATTCCAATTCCTTCATGACCAAG 
Rnpbr CGGTATTTTTCTGTGGCACTGTCC 
Rnpbf CAGCGGCCTATGGCTCTAATC 
AV03_6F GAATCCGTAATCATGGTCATAGCTG 
AV03_4R GCCAAAGCTAATTATTTCATGTCCTGT 
AV03_1R TGTCGGGGCGCAGCCATGA 
AV03_2F AGAGGATCCTTCTGAAATGAGCTG 
AV03_3F CAGAGCCTAATCTTAAAGAATTCGTGG 
 AV03_4F GGGTAAACTATTTGCTGAACAAAATAAATC 
AV03_2R CCGCTTCTGCGTTCTGATTTAATC 
AV03_5F GTTGATCGGCGCGAGATTTAATCG 
AV03_7F CCGTTGAAATTGACCGAGTACTTTCT 
AV03_8F CAGTCGAAAGAGAAATTCATGGACC 
AV03_5R CGCTACGGCGTTTCACTTCTG 
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Chapter 5: Photoautotrophic production of D-lactic acid in 
an engineered cyanobacterium 
This chapter has been reproduced from the following publication: 
Varman, A.M., Yu, Y., You, L., & Tang, Y.J.  Photoautotrophic production of D-lactic acid in an 
engineered cyanobacterium. Microbial Cell Factories, 12, 117 (2013). 
AMV and YY contributed equally for this work. 
Abstract 
Background: The world faces the challenge to develop sustainable technologies to replace 
thousands of products that have been generated from fossil fuels. Due to concerns about food 
security, sugar-based microbial fermentation raises economical questions. Thus, phototrophic 
microbial cell factories serve as promising alternatives for the production of commodity 
chemicals and biofuels. For example, polylactic acid (PLA) with its biodegradable properties is a 
sustainable, environmentally friendly alternative to polyethylene. At present, PLA microbial 
production is mainly dependent on food crops such as corn and sugarcane. Moreover, optically 
pure isomers of lactic acid are required for the production of PLA, where D-lactic acid controls 
the thermochemical and physical properties of PLA. Henceforth, production of D-lactic acid 
through a more sustainable source (CO2) is desirable. 
Results: We have performed metabolic engineering on the cyanobacterium, Synechocystis sp. 
PCC 6803, for the phototrophic synthesis of optically pure D-lactic acid from CO2 by utilizing 
solar energy. Synthesis of optically pure D-lactic acid was achieved by utilizing a recently 
discovered enzyme, (i.e., a mutated glycerol dehydrogenase, GlyDH*).  Significant 
improvements in D-lactate synthesis were achieved through codon optimization and by 
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balancing the cofactor (NADH) availability through the heterologous expression of a soluble 
transhydrogenase (STH). We have also discovered that addition of acetate to the cultures 
improved lactic acid production. More interestingly, 13C based metabolic pathway analysis 
revealed that acetate was not used for the synthesis of lactic acid, but was mainly used for 
synthesis of some biomass building blocks (such as leucine and glutamate). Finally, the optimal 
strain was able to accumulate 1.14 g/L (photoautotrophic condition) and 2.17 g/L (phototrophic 
condition with acetate) of D-lactate in 24 days.  
Conclusions: We have demonstrated the photoautotrophic production of D-lactic acid by 
engineering a cyanobacterium, Synechocystis 6803. The engineered strain shows an excellent D-
lactate productivity from CO2. In the late growth phase, the lactate production rate by the 
engineered strain reached a maximum of 0.19 g D-lactate/L/day (in the presence of acetate). This 
study serves as a good complement to the recent engineering work done on Synechocystis 6803 
for L-lactate production. Thereby, our study may facilitate developments in the use of 
cyanobacterial cell factories for the commercial production of high quality PLA.   
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5.1 Background 
Fossil fuels helped literally ignite the industrial revolution, and from then on radically 
changed the way we live; today, thousands of products are generated from fossil fuels 176.  
Unfortunately, fossil fuels are non-renewable and their reserves will foreseeably run dry.  
Moreover, the reckless use of this resource has resulted in a tremendous release of greenhouse 
gases leading to adverse effects to our earth’s climate and to the creatures living on our planet. 
These drawbacks have driven researchers to look for alternative renewable replacements for 
petroleum and petroleum-derived products.  Amongst the petroleum-derived products; 
polyethylene with an annual productivity of 80 million metric tons per annum stands out as one 
of the most commonly used plastics 177.  Polylactic acid (PLA) is made by the polymerization of 
lactic acid and has the potential to replace polyethylene as a biodegradable alternative 178.  Lactic 
acid is a chiral compound and exists in two isomeric forms: D (-) lactic acid and L (+) lactic acid.  
The various properties of polylactic acid are modulated by the mixing ratio of the D (-) and L (+) 
lactic acid and, henceforth, it is essential to produce both the isomers 179.  It has been estimated 
that for the PLA production to be profitable, the lactic acid price should be less than 0.8$/kg 180. 
This necessitates the production of lactic acid from a cheaper source. Although microbial 
fermentation can produce lactate from sugar-based feedstock, such process may compete with 
global food supplies. Therefore, this work focuses on cyanobacterial process development for the 
sustainable synthesis of D (-) lactic acid, with CO2 as the carbon substrate and sunlight as an 
energy source. 
Cyanobacteria have the ability to reduce atmospheric CO2 into useful organic 
compounds by using solar energy and have been engineered to synthesize a number of value-
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added products 28, 29, 181, 182. Synechocystis sp. PCC 6803 (hereafter Synechocystis 6803) with its 
ability to uptake foreign DNA naturally, has been the model organism of choice for various 
metabolic engineering works 135, 183, 184.  Synechocystis 6803 also has the ability to grow 
mixotrophically with glucose and acetate 185. Therefore, along with CO2, its versatile carbon 
metabolism allows the co-utilization of cheap organic compounds for product biosynthesis. For 
example, acetate abundant wastewater generated from biomass hydrolysis and anaerobic 
digestion 131, can be potentially used for promoting cyanobacterial productivity. More 
importantly, there are numerous molecular biology tools for Synechocystis 6803, making it an 
attractive organism for metabolic engineering works 163, 186.   
Synechocystis 6803 has recently been engineered for the production of L-lactate (a 
maximal titer of 1.8 g/L and a maximal productivity of 0.15 g/L/day) 187-189.  However, 
engineering Synechocystis 6803 for the production of optically pure D-lactate synthesis is more 
difficult due to the lack of an efficient D-lactate dehydrogenase. Recently, a mutated glycerol 
dehydrogenase (GlyDH*) was discovered by Wang et al. 190 and this enzyme was found to 
behave as a D-lactate dehydrogenase, exhibiting an unusually high specific activity of 6.9 units 
per mg protein with pyruvate and NADH as substrates. This enzyme allows a Bacillus coagulans 
strain to produce 90g/L of D-lactate. Their work served as a motivation for us to engineer 
Synechocystis 6803 through the heterologous expression of gldA101 (encodes GlyDH*). We 
found that this original enzyme was able to synthesize optically pure D-lactate in Synechocystis 
6803. To further improve cyanobacterial productivity, we employed three strategies: 1. Codon 
optimization of gldA101 (Supplementary Figure 5.5); 2. Heterologous expression of a 
transhydrogenase; 3. Supplementing cultures with extracellular carbon sources (such as glucose, 
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pyruvate and acetate). The final engineered strain demonstrated a high D-lactic acid productivity 
and titer (titer >1g/L). 
5.2 Results and Discussion 
Cyanobacteria need a lactate dehydrogenase to synthesize lactate from pyruvate (Figure 
5.1). Earlier works on Synechocystis 6803 for lactate production involved the expression of an 
ldh from Bacillus subtilis for synthesis of L-lactate 188. As a first step, we tested the activity of 
GlyDH* for D-lactate production 190 by transferring the gene from Bacillus coagulans to 
Synechocystis 6803.  A plasmid pYY1 was constructed that contained the gene gldA101 under 
the control of an Isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible promoter, Ptrc.  The 
gldA101 gene was then subsequently transferred to the glucose tolerant wild type Synechocystis 
6803 through natural transformation, generating the strain AV08.  The optical density and the D-
lactate concentration of the AV08 cultures were monitored in shake flasks.  As can be verified 
from Figure 5.2, AV08 did not show any significant levels of D-lactate in the initial 12 days.  
The D-lactate levels started increasing steadily at the late autotrophic growth phase and reached a 
final titer of 0.4 g/L, whereas a wild type strain of Synechococcus 7002 was able to produce only 
~ 7 mg/L of D-lactate through glucose fermentation 191. 
A familiar strategy to increase the synthesis of a target product would be to increase the 
levels of the heterologous enzyme inside the cell.  This can be achieved by modifying the 
enzyme regulation either at the transcriptional level or at the translational level.  Cyanobacteria 
are known to have their own preference in the use of codons for synthesizing amino acids 192.  
Lindberg et al. 193 have employed codon optimization for the isoprene synthase gene IspS and 
have found a 10-fold increase in the IspS expression level.  More recently, this strategy was 
80 
 
 
applied to increase the expression of the efe gene (from Pseudomonas syringae) in Synechocystis 
6803 for ethylene production 194.  Since the gene involved in this work was borrowed from a 
gram-positive organism and Synechocystis 6803 being gram-negative, we hypothesized that this 
would be a useful strategy.  The codon optimized gene gldA101-syn (synthesized by Genewiz 
Inc, South Plainfield, NJ) was integrated into the psbA1 gene loci in the genome of the WT 
Synechocystis 6803 using the plasmid pDY3 to obtain the strain AV11.   
Further improvements in product synthesis can be achieved by rectification of 
bottlenecks in the metabolic pathway. The lactate dehydrogenase enzyme utilizes NADH as its 
cofactor, whereas the ratio of NADH to NADPH is reported to be much lower in cyanobacteria. 
For example, the ratio of NADH to NADPH in Synechococcus 7942 under light conditions was 
estimated to be 0.15, and in Synechocystis 6803 under photoautotrophic conditions the 
intracellular NADH concentration was only 20 nmol/g fresh weight, whereas the intracellular 
concentration of NADPH was about 140 nmol/g fresh weight 195-197.  This lower concentration of 
NADH in cyanobacteria, points to the fact that availability of NADH could be a major limiting 
factor for synthesizing D-lactate. Henceforth, a soluble transhydrogenase, sth from Pseudomonas 
aeruginosa 198, was introduced downstream of the gene gldA101-syn. This engineered strain was 
called AV10. The heterologous genes in AV10 and AV11 are under the control of the same 
single promoter, Ptrc, located upstream of gldA101-syn and sth in AV10 and located upstream of 
gldA101-syn in AV11. 
The three strains (AV08, AV10 and AV11) showed similar growth rates to wild type 
strain under photoautotrophic conditions, and thus the production of D-lactate did not introduce 
growth defects in the engineered strains (Figure 5.2A and Figure 5.6). However, the three strains 
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differed in the production rate of D-lactic acid. The strain AV11 with codon optimization 
(gldA101-syn) had an improved productivity for D-lactate compared to the AV08 strain (Figure 
5.2B). Both strains produced D-lactate mainly during the later growth stage. Introduction of the 
transhydrogenase improved the D-lactate synthesis further in AV10, and this strain produced D-
lactate in both the growth phase and non-growth phase.  The rate of photoautotrophic D-lactate 
production by AV10 increased significantly (achieving a maximum productivity of 0.1 g/L/day 
and ~0.2 mmol/g cell/day) during the late phase of the culture and the final titer of D-lactate 
reached 1.14 g/L.   
 We observed that the D-lactate production rate reached its peak in the later stages of 
cultivation, suggesting that more carbon flux has been directed to lactate production during the 
non-growth phase. This increased flux was expected because the lactate precursor (pyruvate) is a 
key metabolic node occupying a central position in the synthesis of diverse biomass components, 
and more pyruvate becomes available for lactate synthesis when biomass growth becomes slow.  
Therefore, an obvious thought would be to enhance lactate production by supplementing the 
cultures with pyruvate 199.  However, our experiments found that addition of pyruvate did not 
yield apparent improvements in D-lactate synthesis (data not shown), possibly because 
Synechocystis 6803 may lack an effective pyruvate transporter. The alternate option would be to 
grow AV10 with glucose and increase the glycolysis flux for pyruvate synthesis. In our previous 
study, addition of glucose was found to increase isobutanol production in Synechocystis 6803 136. 
However in this study, when we grew the AV10 strain under mixotrophic conditions (with 5 g/L 
glucose), it did not show a higher growth rate or display improvements in the final D-lactate titer 
compared to the autotrophic condition.  The AV10 cultures grown in the presence of glucose 
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instead showed an impaired growth, possibly because the engineered pathways caused a 
metabolic imbalance during glucose catabolism (Figure 5.3).   
We also hypothesized that the intracellular pyruvate pool can be increased for lactate 
production by addition of exogenous acetate. Supplementing cultures with acetate can redirect 
more carbon from pyruvate to lactate in three possible ways 200: (1) acetate is used as a building 
block for lactate production; (2) acetate provides additional carbon source for biomass synthesis 
and reduce pyruvate consumption; (3) acetate conversion by acetyl-CoA synthetase consumes 
Coenzyme-A (CoA), decreasing the CoA pool available for pyruvate decarboxylation.  To test 
this hypothesis, the AV10 cultures were supplemented with 15mM acetate. We found that 
growth rate of the AV10 cultures with acetate (Figure 5.3A) remained comparable to their 
growth rate under autotrophic condition, but there was substantial improvement in the synthesis 
of D-lactate (the maximal titer reached 2.17 g/L and the peak productivity reached ~0.19 
g/L/day, Figure 5.3B). 
 To further understand the role played by glucose and acetate in D-lactate synthesis, AV10 
cultures were grown with [1,2-13C] glucose and [1,2-13C] acetate (Sigma, St. Louis).  Cultures 
were collected from the mid-log phase and were used for amino acid and D-lactate analysis. As 
an example, mass spectrum of D-lactate from a cyanobacterial culture is shown in supplementary 
Figure 5.7. The 13C abundance in the amino acids and lactate were obtained as mass fraction mi, 
where ‘i’ indicates the number of 13C in the molecule. As can be seen from Figure 5.4A, glucose-
fed cells have significant 13C-carbon distributed in amino acids (indicated by an increase in m1 
and m2). Also, D-lactate from glucose-fed cultures was partially 13C-labeled (m2 ~0.22). The 
isotopomer data in Figure 5.4A proved that 13C-glucose provided the carbon source for both 
biomass and lactate production. However, glucose-based mixotrophic fermentation is not 
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beneficial to D-lactate production compared to autotrophic cultures, possibly because carbon flux 
from glycolysis may cause some carbon and energy imbalance136. As for the acetate-fed cultures, 
only leucine and glutamate (which both use acetyl-CoA as their precursor) were significantly 
labeled (an m2 of 0.31 and 0.32 respectively), while other amino acids (e.g., aspartate and 
alanine) were nonlabeled (Figure 5.4B). Interestingly, D-lactate from acetate-fed culture was 
almost nonlabeled, indicating that the carbons of lactate molecules were mainly derived from 
CO2. Therefore, the observed enhancement of lactate synthesis in the presence of acetate can be 
explained by two complementary mechanisms. First, acetate is an additional carbon source for 
synthesizing biomass building blocks, such as fatty acids and some amino acids, thus redirecting 
the extra carbon flux from CO2 to lactate. Secondly, acetate may limit the pyruvate 
decarboxylation reaction by reducing the CoA pool by the formation of acetyl-CoA and thus 
improve pyruvate availability for lactate synthesis.  
5.3 Conclusions 
The results reported here are for the autotrophic production of D-lactate in cyanobacteria 
via the heterologous expression of a novel D-lactate dehydrogenase (GlyDH*) and by balancing 
the precursors and cofactors.  Other molecular strategies may also be applied to further improve 
the D-lactate production: (1) by seeking stronger promoters 186; (2) optimizing ribosomal binding 
sites 201; (3) improving activity of GlyDH* via protein engineering; (4) introducing powerful 
lactate transporter 202; (5) knocking out competing pathways (such as the glycogen and 
polyhydroxybutyrate synthesizing pathways); (6) duplicating the heterologous genes by 
integrating at multiple sites 203; and (7) limiting biomass production by knocking down the 
pyruvate decarboxylation reaction. Also, considering the future outdoor algal processes for 
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scaled up D-lactate production, we hypothesize that knocking out metabolic pathways that 
synthesize carbon storage molecules (polyhydroxybutyrate and glycogen) may be deleterious to 
algal growth during the night phase in day-night cultivation 204. On the other hand, process 
optimization by employing better light conditions, along with proper CO2 concentration, pH and 
temperature control, may also be employed to increase the D-lactate productivity in a scaled-up 
system.  
5.4 Materials and methods 
 
5.4.1 Chemicals and reagents. Restriction enzymes, Phusion DNA polymerase, T4 DNA ligase 
and 10-Beta electro-competent E. coli kit were purchased from Fermentas or New England 
BioLabs. Oligonucleotides were purchased from Integrated DNA Technologies (IDT). All 
organic solvents, chemicals, 13C-labeled acetate, and glucose used in this study were purchased 
from Sigma-Aldrich (St. Louis, MO).  
5.4.2 Medium and growth conditions. E. coli strain 10-Beta was used as the host for all 
plasmids constructed in this study. E. coli cells were grown in liquid Luria-Bertani (LB) medium 
at 37°C in a shaker at 200 rpm or on solidified LB plates. Ampicillin (100 µg/mL) or kanamycin 
(50 µg/mL) was added to the LB medium when required for propagation of the plasmids in E. 
coli. The wild-type (glucose-tolerant) and the recombinant strain of Synechocystis 6803 were 
grown at 30°C in a liquid blue-green medium (BG-11 medium) or on solid BG-11 plates at a 
light intensity of 100 µmol of photons m-2s-1 in ambient air. Kanamycin (20 µg/mL) was added 
to the BG-11 growth medium as required. Growth of the cells was monitored by measuring their 
optical density at 730 nm (OD730) with an Agilent Cary 60 UV-vis spectrophotometer. 10 mL 
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cultures for the synthesis of D-lactate were grown (initial OD730, 0.4) in 50 mL shake flasks 
without any antibiotic and 1mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added for 
induction. Mixotrophic cultures of Synechocystis 6803 were started in BG-11 medium containing 
a known amount of glucose (0.5%) or acetate (15mM) as an organic carbon source. 
5.4.3 Plasmid construction and transformation. The vector pTKA3 136 served as the backbone 
for all the plasmids constructed in this study. The gene gldA101 encoding GlyDH* 190, was 
amplified from the plasmid pQZ115 with the primers gldA-o-F2 and gldA-o-R (Table 1 and 2). 
The obtained 1.2 kb fragment was digested with BamHI/NheI and cloned into the same 
restriction sites of pTKA3, yielding the vector pYY1. A gene cassette, which consists of the 
codon optimized gldA101 (gldA101-syn) with the promoter Ptrc in the upstream and the 
transhydrogenase (sth) gene from Pseudomonas aeruginosa 198 in the downstream, was 
chemically synthesized by Genewiz Inc (South Plainfield, NJ) and cloned into the commonly 
used E. coli vector pUC57-kan resulting in the plasmid vector pUC57-glda_sth. The vector 
pUC57-glda_sth was digested with BamHI/NheI, and the yielding 2.6 kb fragment was cloned 
into the corresponding restriction sites of pTKA3, resulting in the vector pDY2. The vector 
pDY3 was constructed by self-ligation of the 8.2 kb fragment obtained through the digestion of 
pDY2 with KpnI.  
Natural transformation of Synechocystis 6803 was performed by using a double 
homologous-recombination procedure as described previously 19. Recombinant colonies 
appeared between 7 and 10 days post inoculation. The genes of interest were finally integrated 
into the psbA1 gene loci (a known neutral site under normal growth conditions) in the genome of 
Synechocystis 6803 136.  For segregation, the positive colonies were propagated continuously 
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onto BG-11 plates containing kanamycin and segregation of colonies was verified through a 
colony PCR with the primers AMV17R and ps1_up_fwda (Table 1). The promoter and the 
heterologous genes in the engineered strains were PCR amplified with respective primers (ptka3-
F, CO-F, O-F, sth-F) (Table 1) and sent for sequencing to Genewiz to verify the cloning 
accuracy. 
5.4.4 D (-) lactate analysis.  D(-)/L(+) lactic acid detection kit (R-biopharm) was used to 
measure the D-lactate concentration. Samples of the cyanobacterial culture (50 µL) were 
collected every 3 days and centrifuged at 12,000 rpm for 5 min. The supernatant was collected 
and the D-lactate concentration assay was performed following the manufacturer’s instruction. 
All the reactions were performed in a 96-well plate reader at room temperature (Infinite 200 
PRO microplate photometer, TECAN). 
5.4.5 13C isotopomer experiment.  To estimate the carbon contributions of glucose and acetate 
for biomass and D-lactic acid synthesis a 13C labeling experiment was performed. The mutant 
AV10 was grown in a BG-11 medium with 0.5% glucose (1,2-13C2 glucose) or 15mM acetate 
(U-13C2 acetate) (Sigma, St. Louis).  Cultures were started at an OD730 of 0.4 and were grown 
with labeled glucose or acetate for over 48 hours. The biomass samples and supernatant were 
collected for measurement of lactate and amino acid labeling.  
The proteinogenic amino acids from biomass were hydrolyzed and then derivatized with 
TBDMS [N-(tert-butyldimethylsilyl)-N-methyl-trifluoroacetamide], as described previously 160. 
The derivatized amino acids were analyzed for their 13C mass fraction by GC-MS (Hewlett 
Packard 7890A and 5975C, Agilent Technologies, USA) equipped with a DB5-MS column 
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(J&W Scientific) 160. The fragment [M-57]+ containing information of the entire amino acid was 
used for calculating the 13C mass fractions (M: the molecular mass of the derivatized amino 
acids). The fragment [M-15]+ was used only for leucine, since its [M-57]+ overlaps with other 
mass peak 205. To analyze extracellular D-lactic acid labeling, the supernatant (0.2 mL) was first 
freeze-dried at -50 oC. The dried samples were then pre-derivatized with 200 µL of 2% 
methoxyamine hydrochloride in pyridine for 60 minutes at 37 °C and then derivatized with 300 
µL N-Methyl-N-(trimethylsilyl) trifluroacetamide (TMS) for 30 minutes at room temperature. 
The natural abundance of isotopes, including 13C (1.13%), 18O (0.20%), 29Si (4.70%) and 30Si 
(3.09%) changes the mass isotopomer spectrum. These changes were corrected using a published 
algorithm and the detailed measurement protocol can be found in our previous paper 206. 
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Table 5.1:  Primer sequences 
Primer name Sequence (5’→ 3’) 
gldA-o-F GGATCCTTGACAATTAATCATCCGGCTCG 
gldA-o-F2 GGATCCTTGACAATTAATCATCCGGCTCGTATAATGTGTGGAATTGT
GAGCGGATAACAATTTCACACAGGAGATATAATCATATGACGAAAA
TCATTACCTCTCCAAGCAAGTTTATACAAGG 
gldA-o-F3 ATGACGAAAATCATTACCTCTCCAAG 
gldA-o-R GCTAGCTCATGCCCATTTTTCCTTATAATACCGCCCG 
gldA-o-R2 TTAGGCCCACTTTTCCTTGTAATAGC 
tranNADH-F CCTAAGCTAGCGGAGGACTAGCATGG 
tranNADH-R GCTAGCGGTACCTCAAAAAAGCCGG 
ptka3-F CCCGAAGTGGCGAGCCCGAT 
CO-F TTGATGTTGCCTTTGAACCC 
O-F ATGGATACGAAAGTGATTGC 
sth-F GAGCTACCACCTGCGCAACA 
AMV17R GCGCGACTCCCCGTCTTTGACTATCCTTTTTAGGATGGGGCA 
ps1_up_fwda TACCGGAACAGGACCAAGCCTT 
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Table 5.2:  Plasmids and strains  
 
Plasmids/Strains Description Source or reference 
Plasmids 
pUC57-glda_sth Chemically synthesized gene cassette consisting 
of Ptrc, gldA101-syn and sth.  
Genewiz; 190, 198 207 
pQZ115 Plasmid carrying gldA101 190 
pTKA3 Backbone plasmid for all vectors constructed in 
this study, with psbA1 as the integration loci. 
136 
pYY1 Derived from pTKA3 with gldA101 and the 
promoter, Ptrc.  
This study 
pDY2 Derived from pTKA3 with gldA101-syn, sth 
and the promoter, Ptrc. 
This study 
pDY3 Derived from pTKA3 with gldA101-syn and the 
promoter, Ptrc.  
This study 
Strains 
E. coli 10-Beta Cloning host strain. New England 
Biolabs 
Synechocystis sp. PCC 
6803 
Glucose tolerant wild type, naturally competent. This study 
AV08 Synechocystis Ptrc::gldA101::Kmr, GlyDH*of 
Bacillus. This study 
AV10 Synechocystis Ptrc::(gldA101-syn)-sth::Kmr, 
GlyDH* of Bacillus, transhydrogenase of 
Pseudomonas. 
This study 
AV11 Synechocystis Ptrc::gldA101-syn::Kmr, GlyDH* 
of Bacillus. This study 
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Figure 5.1A 
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Figure 5.1B 
 
Figure 5.1: Metabolic engineering of Synechocystis 6803 for the synthesis of D-lactic acid. (A) 
Metabolic pathway for D-lactate synthesis. Lactate permeation through the cell membrane occurs 
either via a lactate transporter or by passive diffusion202, 208.  Red arrows indicate the 
heterologous pathway engineered into Synechocystis 6803. Abbreviations: GlyDH*, mutant 
glycerol dehydrogenase; TH, Transhydrogenase; 3PGA, 3-phosphoglycerate; CoA, Coenzyme 
A; G1P, glucose 1-phosphate; F6P, fructose 6-phosphate; PHB, poly-β-hydroxybutyrate; RuBP, 
ribulose 1,5-bisphosphate. (B) Colony PCR to verify the presence of the heterologous genes of 
the  mutant glycerol dehydrogenase (Left picture) and transhydrogenase (Right picture) in the 
engineered strains of Synechocystis 6803.  gldA101 was amplified with primers gldA-o-F3 and 
gldA-o-R; gldA101-syn was amplified with primers gldA-o-F and gldA-o-R2; sth was amplified 
with primers tranNADH-F and tranNADH-R (Table 5.1). 
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Figure 5.2A 
 
Figure 5.2B 
  
Figure 5.2: Autotrophic production of D-lactate in the engineered strains of Synechocystis 6803.  
(A) Growth curves and (B) D-lactate production in the engineered strains (n = 3).  Circles: AV08 
(with gldA101). Triangles: AV10 (with gldA101-syn and sth) and Squares: AV11 (with gldA101-
syn). 
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Figure 5.3A 
 
Figure 5.3B 
 
Figure 5.3:  Mixotrophic production of D-lactate by AV10. (A) Growth and (B) D-lactate 
production in the engineered Synechocystis 6803 strain AV10 (n = 3), with the provision of 
additional organic carbon source, i.e., with glucose and acetate (Mixotrophic metabolism). 
Squares: with acetate. Circles: with glucose. 
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Figure 5.4A 
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Figure 5.4B 
 
Figure 5.4:  Isotopomer analysis showing the mass fraction of isotopomers for selected 
proteinogenic amino acids [TBDMS based measurement] and D-lactate [MSTFA based 
measurement]. Standard abbreviations are used for amino acids in the figure. (A) Cultures grown 
with 5 g/L of [1,2-13C] glucose and (B) Cultures grown with 15 mM of [1,2-13C] acetate. “white 
bar” m0 – mass fraction without any labeled carbon; “grey bar” m1 – mass fraction with one 
labeled carbon; “black bar” m2 – mass fraction with two labeled carbon. (Note: natural 13C 
makes up about 1.1% of total carbon as measurement background) 
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Figure 5.5:  Nuleotide sequence alignment of gldA101 and the codon-optimized gldA101 (i.e., 
gldA101-syn, synthesized by Genewiz Inc). Conserved nucleotide sequences in gldA101-syn are 
indicated as dotted lines. 
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Figure 5.6:  Autotrophic growth curve for Synechocystis 6803 strains shows similar growth of 
the engineered D-lactate producing strains as compared to the wild type strain. Diamond: Wild 
type. Square: AV08. Triangle: AV10. Circle: AV11.  
 
 
Figure 5.7:  Mass spectra obtained via GC-MS confirm the presence of lactate in the cell culture 
supernatant of AV10 strain. D/L lactate enzyme kit (R-Biopharm) was used to further confirm 
that the product is an optically pure D-lactate. 
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Chapter 6: Kinetic modeling and isotopic investigation of 
isobutanol fermentation by two engineered Escherichia coli 
strains  
This chapter has been reproduced from the following publication: 
Varman, A.M., Xiao, Y., Feng, X., He, L., Yu, H.,  & Tang, Y.J. Kinetic Modeling and Isotopic 
Investigation of Isobutanol Fermentation by Two Engineered Escherichia coli Strains. Industrial 
& Engineering Chemistry Research 51, 15855-15863 (2012). 
AMV, YX, and XF contributed equally to this work. 
Abstract 
We constructed an E. coli BL21 strain with the Ehrlich pathway (the low performance 
strain for isobutanol production). We also obtained a high isobutanol-producing E. coli strain 
JCL260 from the James Liao group (University of California). To compare the fermentation 
performances of the two engineered strains, we employed a general Monod-based model coupled 
with mixed-growth-associated isobutanol formation kinetics to simulate glucose consumption, 
biomass growth, and product secretion/loss under different cultivation conditions. Based on both 
kinetic data and additional 13C-isotopic investigation, we found that the low performance strain 
demonstrated robust biomass growth in the minimal growth medium (20 g/L glucose), achieving 
isobutanol production (up to 0.95 g/L). It utilized significant amount of yeast extract to 
synthesize isobutanol when it grew in the rich medium. The rich medium also enhanced waste 
product secretion, and thus reduced the glucose-based isobutanol yield. In contrast, JCL260 had 
poor biomass growth in the minimal medium due to an inflated Monod constant (Ks), while the 
rich medium greatly promoted both biomass growth and isobutanol productivity. With the 
optimized keto acid pathway, JCL260 synthesized isobutanol mostly from glucose even in the 
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presence of sufficient yeast extract. This study not only provided a kinetic model for scaled-up 
isobutanol fermentation, but also offered metabolic insights into the performance tradeoff 
between two engineered E. coli strains. 
Key words: 13C-isotopic, Ehrlich pathway, mixed-growth-associated, tradeoff, yeast extract 
6.1 Introduction 
 
Biobutanols are second generation biofuels that have higher energy density and lower 
water solubility than ethanol. Acetone-butanol-ethanol (ABE) fermentation is a traditional 
bioprocess that uses Clostridium acetobutylicum to produce n-butanol, but such a process is 
restrained by the slow alcohol production rate 209. To overcome this restriction, the n-butanol 
pathway derived from Clostridium has been reconstructed in fast-growing E. coli or yeast strains 
23, 24, 118, 210. Butanol biosynthesis via the Clostridium pathway has limitations including low 
product titer and yield due to the accumulation of toxic metabolites. Another approach is via the 
keto-acid pathway to produce low-toxicity isobutanol (IB), 25 where the amino acid biosynthesis 
pathways and the Ehrlich pathway are incorporated for alcohol synthesis 26, 27. This method 
shows effective production of higher alcohols because of robust and ubiquitous amino acid 
pathways. 
Table 6.1 summarizes diverse biobutanol production strategies, including the 
overexpression of the targeted pathway in different microbial hosts (including photoautotrophic 
microbes), the elimination of competing pathways, the systems redesign of host metabolism, and 
the integration of fermentation with in situ product separation. However, few papers have studied 
the kinetics of engineered microbial hosts for biobutanol fermentation. To apply a newly 
developed host in the biofuel industry, a kinetic-based model is of practical importance not only 
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for designing optimal scaled-up fermentation, but also for understanding the internal metabolic 
features of microbial hosts in responses to various nutrient sources and cultivation conditions. To 
fulfill this gap, our lab has created an E. coli mutant that produces IB via the Ehrlich pathway. 
Meanwhile, we have obtained a high performance E. coli strain JCL260 with an optimized 
metabolism for IB synthesis (offered by the James Liao group)130.  Based on fermentation data 
using both strains, we developed an empirical model to analyze and compare their fermentation 
kinetics. We also performed 13C-experiments to investigate the nutrient use of the two mutant 
strains for the synthesis of biomass and IB.  
6.2 Materials and Methods 
 
6.2.1 Pathway construction  
            We engineered E. coli BL21 (DE3) by heterologous expression of Kivd (2-
ketoisovalerate decarboxylase) and AdhA (aldehyde reductase). The two genes were amplified 
from Lactococcus lactis by PCR with high fidelity DNA polymerase Pfx (Invitrogen). Primers 
for kivd:5’-gacactcgagtaatgtatacagtaggagattac-3’; 5’-tgcgggtaccttatgatttattttgttc-3’. Primers for 
adhA: 5’-tcaactagtggtaccaggagatataatatgaaagcagcagtagtaagac-3’; 5’-
atttgcggccgcgcatgcttatttagtaaaatcaatgac-3’. The genes kivd (treated with XhoI / KpnI) and adhA 
(treated with KpnI / SphI) were cloned into the pTAC-MAT-Tag-2 Expression Vector (Sigma-
Aldrich) via XhoI / SphI to create the plasmid pTAC-KA, and then transformed into E. coli 
BL21 (DE3). This low performance mutant used its native valine biosynthesis pathway to 
generate 2-ketoisovalerate, and then converted it to IB by the heterologous Ehrlich pathway (Fig. 
6.1). To confirm the expression of Kivd and AdhA, we performed SDS-PAGE analysis of the 
recombinant strain and observed the protein bands of Kivd (~ 60 kDa) and AdhA (~ 35 kDa). 
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The strain secreted IB, acetate, lactate, ethanol, and a small amount of n-propanol and methyl-
butanol (similar product profiles to other IB producing E. coli strains) 25. Additionally, Professor 
James Liao from University of California offered us an E. coli strain JCL260 with plasmids 
pSA65 and pSA69 211. This high performance strain not only contains two plasmids that 
overexpress the entire IB pathway, but also has gene deletions to interfere with waste product 
(acetate, formate, ethanol, succinate, and lactate) biosynthesis. 
6.2.2 Fermentation conditions   
           Fermentations were performed in a New Brunswick Bioflo 110 fermentor with a dissolved 
oxygen (DO) electrode, a temperature electrode, and a pH meter.  The 100% DO was defined as 
the point where the cell-free medium was purged by air (~2 L/min) for 15 minutes. In the oxygen 
limited fermentations (air rate = 0 L/min), the DO dropped to 0% during the exponential growth 
phase. Two culture media were used: (a) a minimal medium that contained 2% glucose, M9 salts 
(Difco), 10 mg/L vitamin B1, and 50 mg/L ampicillin; and (b) a rich medium containing the 
minimal medium with 5 g/L yeast extract. To start each fermentation, 400 ml of culture was 
inoculated with 5 ml of overnight LB culture (OD600~3) of the recombinant E. coli strain. The 
cultivation conditions were: pH = 7.0 (controlled by adding 2 mol/L NaOH via an auto-pump), 
temperature = 30 °C, and stirring speed = 200 rpm. For all fermentations, cells were first grown 
in aerobic conditions (DO>50%) before adding 0.2 mM IPTG (Isopropyl β-D-1-
thiogalactopyranoside). Right after IPTG induction, we imposed two O2 conditions: 1) in aerobic 
conditions, air (flow rate: ~1 L/min) was bubbled into the bioreactor to provide O2 and to remove 
IB (i.e., gas stripping) from the bioreactor; 2) in O2 limited conditions, air was turned off and the 
DO was maintained zero during IB production. For the low performance strain, we had three 
fermentations: F1 (minimal medium and aerobic conditions), F2 (minimal medium and O2 
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limited conditions), and F3 (rich medium and O2 limited conditions). For JCL260, we had two 
fermentations (F4: minimal medium and aerobic conditions; F5: rich medium and aerobic 
conditions).  
6.2.3 Analytical methods for biomass and metabolites  
             Culture samples were taken after IPTG induction, ~3 ml of culture was taken from the 
bioreactor at each time point for metabolite and biomass analysis. Biomass growth was 
monitored by optical density OD600. There was a linear relationship between the dry cell weight 
and OD600. To measure dry biomass weight, biomass samples were harvested by centrifugation, 
washed with DI water, and dried at 100°C until their weight remained constant. Glucose, 
ethanol, acetate, and lactate were measured using enzyme kits (R-Biopharm). Alcohols could be 
detected using GC (Hewlett Packard model 7890A, Agilent Technologies, equipped with a DB5-
MS column, J&W Scientific) and a mass spectrometer (5975C, Agilent Technologies). The GC-
MS detected ethanol, IB, propanol and methyl-butanol. The IB concentration was determined by 
a modified GC-MS method. 118 Briefly, 400 µl of supernatant was extracted with 400 µl of 
toluene (Sigma-Aldrich) by 2-min vortex, followed by high-speed centrifugation (16000×g). The 
organic layer was taken for GC-MS analysis under the following program: hold at 70 °C for 2 
min, ramp to 230 °C at 20 °C min-1, and then hold at 300 °C for 6 min. The carrier gas was 
helium. The MS scan mode was from m/z 20 to 200. Samples were quantified relative to a 
standard curve of IB concentrations for MS detection, and methanol was taken as an internal 
standard. 
6.2.4 13C-experiments for analyzing nutrient contributions to isobutanol productions 
            In the 13C-experiments, the minimal medium with 2% fully labeled glucose (Cambridge 
Isotope Laboratories) was supplemented with 1 g/L or 5 g/L yeast extract (Bacto). By measuring 
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13C-abundance in key metabolites from the engineered strains, we estimated the contribution of 
yeast extract (non-labeled) to biomass and IB synthesis in the 13C-glucose medium. Specifically, 
5 ml of cultures (with 13C-glcuose and yeast extract) were inoculated with 5 µl of overnight LB 
culture of the engineered strain in a 50 ml falcon tube with a closed cap (shaking at 200 rpm, 
30°C). The cultures (JCL260 or the low performance strain) were induced by 0.2 mM IPTG 
(when OD600>0.2), and the samples were taken (at t=~24 hours, middle-log growth phase) for 
isotopomer analysis of IB and amino acids. The two mass-to-charge peaks (m/z=74 for unlabeled 
IB and m/z=78 for labeled IB) were quantified. Their ratio approximately corresponded to the 
ratio of IB synthesized from unlabeled yeast extract vs. labeled glucose. Concurrently, we did 
isotopic analysis of proteinogenic amino acids to identify the incorporation of unlabeled carbon 
from yeast extract into biomass protein. The measurements were based on a GC-MS protocol, 
using TBDMS (N-(tert-butyldimethylsilyl)-N-methyl-trifluoroacetamide, Sigma-Aldrich) to 
derivatize hydrolyzed amino acids from the biomass 161. The m/z ions [M-57]+ from 
unfragmented amino acids were used for analysis except leucine and isoleucine. Because of 
overlapping ions with [M-57]+, the [M-159]+ was used to calculate the isotopomer labeling 
information of leucine and isoleucine 162. 
6.2.5  Model formulation  
           We developed a kinetic model to describe the fermentation data after IPTG induction. The 
model contained six time-dependent process variables:  X, ACT, LACT, EtOH, IB, and Glu, 
which represented the concentrations of biomass, acetate, lactate, ethanol, IB, and glucose, 
respectively. The biomass growth model consisted of glucose-associated (RX) and yeast-extract-
associated (RX,YE) terms. IB production was simulated by a mixed-growth-associated product 
formation model (Eq. 6.5), where β was the non-growth associated IB production rate. In Eq. 
104 
 
 
6.1~6.6, kd was the cell death rate; YAL was the acetate yield from lactate (equal to 0.67 g ACT/g 
LACT, based on a 1:1 mol ratio); YXG, YAG, YEG, YLG, and YIG were the growth associated 
glucose yields to biomass, acetate, ethanol, lactate, and IB. kIB was the removal rate of IB due to 
gas stripping under aerobic fermentation F1, F4 and F5. In F2 and F3, IB loss was minimal (kIB 
was set to zero). A first-order kinetic parameter (kact) was used to describe acetate production 
from lactate. 
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Rx represented a growth model with Monod constant KS and maximum specific rate coefficient 
μmax,app. Since acetate inhibited E. coli growth by decreasing the intracellular pH, a non-
competitive inhibition KiA was included in the model 212. The dependence of the glucose-based 
growth rate on oxygen (i.e., aerobic growth vs. anaerobic growth) was implicitly included in the 
calculation of μmax,app (i.e., the oxygen conditions affected μmax,app). αAX, αEX, αLX, and αIBX were 
the growth-associated yields of acetate, ethanol, lactate, and IB, respectively. In the rich medium, 
the yeast extract was quickly consumed to support biomass growth. The model included a yeast-
extract-associated biomass growth rate RX,YE using a two-parameter exponential decay function 
Eq. 6.12. Table 6.2 summarized model parameters and their units. 
         For each batch culture, unknown parameters were determined by minimizing the sum of 
the squares of the differences between the model’s predictions and the experimentally observed 
growth and metabolite profiles 213. The “ode23” command in MATLAB (R2009a, Mathworks) 
solved the differential equations, while the “fmincon” command searched suitable values of 
parameters. To reduce the risk of having local solutions during the nonlinear parameter 
estimation, we tested the initial guesses for 30 times within the range of possible values to 
identify the global solution. To evaluate the quality of the parameter estimates, we checked the 
sensitivity of the estimated parameters to the measurement inaccuracies. Fifty simulated 
fermentation data sets (including both biomass and metabolite data) were generated by the 
addition of normally distributed measurement noise to the fermentation data set (i.e., randomly 
perturbed the measured data by 30%). The same data-fitting algorithm found new sets of 
parameters. From the probability distribution of these parameter distributions, standard 
deviations of model-fitted parameters were estimated. 
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6.3 Results and discussion 
 
6.3.1 Isobutanol fermentation results  
           In this study, both engineered E. coli strains employed the Ehrlich pathway (Fig. 6.1), 
where 2-ketoisovalerate from valine metabolism is redirected to IB synthesis. For the low 
performance strain, we simply over-expressed 2-ketoisovalerate decarboxylase and alcohol 
dehydrogenase. For strain JCL260, both the Ehrlich pathway and 2-ketoisovalerate synthesis 
pathway were overexpressed. This strain also had gene deletions involved in by-product 
formation to increase pyruvate for IB synthesis, so it was reported to produce 22 g/L of IB in 112 
hrs. 25  
         This study compared IB fermentation kinetics between the two strains.  For the low 
performance strain, ethanol and lactate were barely detected in the aerobic conditions (Fig. 6.2). 
IB titer only reached (0.2 g/L) in F1, because the in situ removal of IB was considerable (the 
airflow carried IB out of the fermentor). Such gas stripping is an effective strategy to avoid the 
IB accumulation in the culture that causes the inhibitory effect on alcohol production 211.  In O2 
limited conditions, the F2 generated 0.95 g/L IB, 1.5 g/L ethanol, 2.2 g/L acetate, and 5.1 g/L 
lactate, while the lactate was reused in the late fermentation stage (stationary growth phase). 
With the addition of yeast extract, the F3 had fast biomass growth (Fig. 6.4). The cell density 
reached a peak (2 g DCW/L biomass) after seven hours of IPTG induction, and glucose was 
consumed within ~12 hours (compared to ~40 hours in the F1 and F2). The high rates for 
biomass growth promoted IB production rate. It took the F3 15 hours to generate 0.6 g/L IB, 
while it took F2 40 hours to generate same amount of IB. The addition of yeast extract also 
resulted in a large amount of growth-associated organic acids (6.0 g/L lactate and 3.6 g/L 
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acetate), and thus decreased IB yield from glucose (0.7 g/L IB and 2.0 g/L ethanol from the F3). 
A recent paper reported that JCL260 accumulated up to 7 g/L IB in an aerobic batch culture 
using the culture media containing 55 g/L glucose, 2.2 g/L sodium citrate, 25 g/L yeast extract, 
and complex trace metal solution 211. This study performed two aerobic fermentations using 
JCL260. In the complete minimal medium with 20 g/L glucose (F4, Fig. 6.5), JCL260 had very 
slow biomass growth and low IB titer (~0.1 g/L). When yeast extract (5 g/L) was supplemented 
(F5, Fig 6.6), IB productivity was significantly improved and its titer reached ~1 g/L (over 
fivefold higher than the low performance strain). Meanwhile, JCL260 produced only 1 g/L 
acetate (two times lower than the low performance strain) because of the deletion of 
phosphotransacetylase (pta) 211. 
6.3.2 Kinetic modeling of isobutanol fermentation  
The same kinetic model simulated fermentation processes by two IB producers. Table 6.2 lists 
the kinetic parameters obtained by nonlinear parameter fitting. For the low performance strain, 
the specific growth rate μmax,app (0.015 h-1) in the oxygen limited conditions was lower than that 
in the aerobic culture conditions (0.051 h-1). IB could be synthesized in both growth and 
stationary phases. The O2 limited condition reduced growth associated IB yield, but promoted 
non-growth associated IB production (e.g., β = 0.012 g IB/g biomass∙h in the F2). In the presence 
of yeast extract, the yeast extract associated biomass growth rate (μmax,YE=0.48 hr-1) was one 
order of magnitude higher than glucose-associated growth rates. The addition of yeast extract 
(F3) also improved the biomass yield coefficient (YXG = 0.20) and the growth associated IB 
production (αIBX = 0.78 g IB/g biomass). Meanwhile, the yeast extract increased yield 
coefficients of waste products (YAG, YEG, YLG) in the F3. The IB yield coefficient YIG was 0.26 g 
IB/g glucose under aerobic respiration, higher than YIG under O2 limited conditions (F2 and F3).  
108 
 
 
For JCL260, the fermentation data indicated that the strain had a highly inflated Monod constant 
Ks (10 g/L), which caused the biomass growth rate to be slower than that of the low performance 
strain. The slow growth led to poor IB synthesis in F4 (αIBX=0.06 g IB/g biomass). Because of 
the knockout of the pta gene to reduce acetate synthesis, the growth associated acetate 
production αAX in F4 was 0.35 g acetate/g biomass, suggesting that acetate production rate was 
reduced compared to the low performance strain (αAX =0.62 g acetate/g biomass in the F1). On 
the other hand, JCL260 still generated acetate after pta deletion 211. The alternate acetate 
pathways in JCL260 had higher glucose associated acetate yield (YAG) than that of the low 
performance strain under aerobic conditions. This observation was consistent with the fact that 
JCL260 (the strain with multiple gene knockouts) had a poor respiration rate, and thus higher 
fraction of glucose was converted to biomass (i.e., YXG also increased) and byproducts rather 
than degraded to CO2. When yeast extract was added to the growth media, the growth associated 
IB production αIBX was 3.3 g IB/g biomass, which was about 5.7 folds higher than that of the low 
performance strain. The addition of nutrients improved the JCL260 biomass growth, the cell 
energy (such as NADH) generation, and the carbon flux through the IB pathway. In contrast, the 
low performance strain had a suboptimal IB pathway. Therefore, yeast extract only enhanced 
metabolic overflows to waste metabolites rather than improving IB titers (the F3).  
         Finally, the continuous flow of air into the bioreactor performed an in situ stripping of IB 
out of the reactor in the aerobic conditions (F1, F4 and F5). Using the model, we estimated the 
total IB production by JCL260 without any loss by gas stripping (i.e., kIB = 0, Fig. 6.6). The 
model showed that the total IB could reach 5 g/L in F5. This result indicated that the IB 
production can be significantly improved via the integration of IB fermentation with a 
downstream product recovery process.   
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6.3.3 Analysis of the role of yeast extract for isobutanol synthesis  
             Nutrient supplements plays important role in improving fermentation performance. Rich 
media have been commonly used for butanol fermentations 25, 118, 214. In addition to providing the 
building blocks for biomass growth, E. coli can also utilize the Ehrlich pathway to convert 
protein hydrolysates to higher alcohols 215. However, the contribution of rich nutrient (yeast 
extract) to IB production was not quantified. Here, we used 13C-experiments to determine the 
ratio of carbon utilization from two different sources (nonlabeled yeast extract vs. fully labeled 
13C-glucose) under oxygen limited conditions via GC-MS analysis (Fig. 6.7). For the low 
performance strain cultivation with 1 g/L yeast extract, its proteinogenic amino acids (e.g., 
histidine, leucine, isoleucine, lysine, and proline) were highly imported from exogenous amino 
acids (>50%, corresponding to the 12C-dilutions), while IB was mostly labeled with four carbons 
(m/z=78, IB came from labeled glucose). When excess yeast extract (5 g/L) was provided, the 
low performance strain not only used yeast extract as the building blocks for cell growth, but 
also converted it to IB (~50% IB was nonlabeled). On the other hand, with sufficient yeast 
extract (5 g/L), JCL260 still mainly used 13C-glucose for IB production (labeled IB was > 90%). 
In the rich media, JCL260 highly utilized yeast extract for biomass synthesis. It showed much 
higher 13C-labeling concentration (~20%) in valine than the low performance strain (~5%). 
Higher abundance of 13C-labeling in valine proved that the overexpression of the keto acid 
pathway in JCL260 efficiently enhanced the 13C-glucose flux towards 2-ketoisovalerate (the 
common precursor for both IB and valine) and reduced the relative valine uptake from the rich 
media.  
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6.4 Concluding remarks  
 
This study developed a general empirical model for IB fermentations by two engineered 
E. coli strains. The model with nonlinear fitted parameters reasonably well described batch 
fermentation data under denoted cultivation conditions. The model results indicated that the two 
strains displayed a difference in biomass growth behavior and products generation. The 
comparative study revealed the change of influential kinetic variables in responses to the 
cultivation conditions. Moreover, we quantified the contribution of nutrient sources to product 
yields via isotopic investigation, and proved that the keto-acid pathway was a rate-limiting step 
for IB production in the low performance strain. This study may serve as a springboard for 
developing useful bioprocess models for higher alcohols fermentations in the biotechnology 
industry.   
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 Table 6.1:  Recent studies on biobutanol production by engineered microorganisms 
Products Substrate Host cell Titer Research Highlights Ref 
IB Glucose E. coli 22 g/L Introduction of a non-fermentative pathway to 
produce IB; elimination of competing pathways to 
reduce waste metabolite secretion 
25 
IB Glucose E. coli 50 g/L In situ IB removal from the bioreactor using gas 
stripping 
211 
IB CO2 Synechococcus 
elongatus 
~0.4 g/L Overexpression of both non-fermentative pathway 
and Rubisco for autotrophic IB production 
28 
IB Cellulose Clostridium 
cellulolyticum 
0.66 g/L Direct conversion of cellulose to IB using 
engineered cellulolytic bacterial species 
10 
IB Glucose E. coli 1.7 g/L A strain optimized for IB production via 
elementary mode analysis  
216 
IB Glucose E. coli 13.4 g/L Utilization of the NADH-dependent enzyme in 
keto-acid pathway to alleviate co-factor imbalance 
114 
IB 
 
Amino 
acids 
E. coli ~2 g/L        
 
 
Utilization of protein hydrolysates for higher 
alcohols synthesis by introducing enzymes for 
exogenous transamination and deamination cycles 
215 
 
IB CO2 Ralstonia 
eutropha 
~1 g/L        
 
Developing an electromicrobial process to convert 
CO2 to higher alcohols 
217 
Butanol Glucose E. coli 1 g/L 
 
A strain engineered for 1-butanol and 1-propanol 
production via isoleucine biosynthesis pathway 
218 
Butanol Galactose Saccharomyces 
cerevisiae 
2.5 mg/L Overexpression of n-butanol pathway derived from 
Clostridium  
 
Butanol Glucose E. coli 4.6 g/L Increase of the barrier for the reverse reaction of 
butyryl-CoA to crotonyl-CoA via trans-enoyl-CoA 
reductase 
118 
Butanol Gluocse E. coli 30 g/L Use of trans-enoyl-CoA reductase and optimization 
of NADH & acetyl-CoA driving forces 
24 
Butanol CO2 Synechococcus 
elongatus  
14.5 
mg/L 
Anaerobic production of 1-butanol from CO2 using 
CoA-dependent butanol pathway 
29 
Butanol Glucose E. coli ~14 g/L        
 
Utilization of a functional reversal of the beta-
oxidation cycle for the synthesis of alcohols 
109 
Butanol CO2 Synechococcus 
elongatus  
30 mg/L 
 
Driving butanol synthesis pathway forward via an 
engineered ATP consumption 
175 
 
 
 
 
112 
 
 
Table 6.2:  Parameters of Monod model for E. coli IB fermentation 
 
 Notations Units F1 F2 F3 F4 F5 
KS Monod constant g/L 0.32±0.05 a 0.32±0.05  0.32±0.05  10 ±1 c 10 ±1 
KiA Acetate inhibition  g/L 49±11 a 49±11  49±11  1.0 ± 0.2 c 1.0 ± 0.2 
μmax,app Specific growth rate  /h 0.051±0.004 0.015±0.001 b 0.015±0.001  0.12± 0.01 c  0.12± 0.01  
YXG Biomass yield from glu g biomass/g 
glu 
0.18±0.03 0.14±0.01 0.20±0.04 0.38±0.01 0.39±0.03 
YAG Acetate  yield from glu g acetate/g 
glu 
0.076±0.007 0.083±0.004 0.33±0.07 0.32±0.01 0.35±0.02 
YEG Ethanol yield from glu g ethanol/g 
glu 
NA 0.26±0.01 0.40±0.05 NA NA 
YLG Lactate yield from glu g lactate/g 
glu 
NA 0.56±0.01 0.91±0.10 NA NA 
YIG IB yield from glu g IB/g glu 0.26±0.05 0.033±0.001 0.19±0.04 0.22±0.01 0.36±0.02 
αAX Growth associated 
acetate synthesis 
g acetate/g 
biomass 
0.62±0.02 0.30±0.01 3.0±0.2 0.35±0.01 0.51±0.03 
αEX Growth associated 
ethanol synthesis 
g ethanol/g 
biomass 
NA 3.7±0.2 4.0±0.2 NA NA 
αLX Growth associated 
lactate synthesis 
g lactate/g 
biomass 
NA 14±1 14±1 NA NA 
    αIBX Growth associated IB 
synthesis 
g IB/g 
biomass 
0.58±0.05 0.078±0.01 0.78±0.06 0.06±0.01 3.3±0.l 
kd Cell death rate /h 0.010±0.002 0.001±0.0002 0.010±0.001 0.02±0.01 0 ± 0.001 
kIB gas stripping rate  /h 0.11±0.02 NA NA 0.11±0.01 0.11±0.01 
kact acetate production from 
lactate 
(h∙g 
biomass/L)-1 
NA 0.013±0.001 0.0034±0.00
02 
NA NA 
kYE Yeast extract 
consumption rate  
/h NA NA 0.55±0.03 NA 0.65±0.05 
μmax,YE Apparent specific 
growth rate with yeast 
extract 
/h NA NA 0.48±0.03 NA 0.32±0.03 
β Non-growth associated 
IB production  
g  IB/ 
        (g biomass∙h) 
0.002±0.002 0.012±0.001 0.006±0.0 0±0.0 0±0.0 
 
 
a): model assuming same values for F1, F2, and F3. b): model assuming same values for F2 and 
F3. c): model assuming same values for F4 and the F5. NA: not applicable. 
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Figure 6.1:  Metabolism in the E. coli strains for IB production. RX, RX,YE, RA, RE, RL, and RIB 
were shown in the Equations 6.1~6.12. IB synthesis consumes one mole NADPH (by keto-acid 
reductoisomerase) and one mole NADH (by aldehyde reductase). The cell met metabolism 
removes the redundant NADH by O2 oxidization or by synthesis of lactate and ethanol. 
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Figure 6.2:  Growth kinetics after IPTG induction (F1). The circles were experimental 
measurements, and the solid lines were simulations from the Monod kinetic model (same as Fig. 
6.3~Fig. 6.6). 
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Figure 6.3:  Growth kinetics after IPTG induction (F2). 
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Figure 6.4:  Growth kinetics after IPTG induction (F3, biomass growth data were from two 
identical batch experiments). 
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Figure 6.5:  Growth kinetics after IPTG induction (F4). 
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Figure 6.6:  Growth kinetics after IPTG induction (F5).The dotted line was model prediction of 
IB concentrations without gas stripping. 
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Figure 6.7:  The fraction of 13C carbon in metabolites from the low performance (A) and 
JCL260 (B) IB-producing strains. The biomass was grown on fully labeled 13C-glucose, with 1 
g/L (black bar) or 5 g/L (gray bar) nonlabeled yeast extract (n=2, GC-MS standard errors < 
2%).The 13C fractions (R) of metabolites were based on the following equation:   
∑
=
⋅=
n
X
XMxn
R
0
)(1
where n was the total carbon number of the metabolite (0 ≤ x ≤ n). Mx was 
the corresponding 13C isotopomer fraction for each isotopomer (M0 was unlabeled fraction, M1 
was singly labeled fraction, M2 was doubly labeled fraction, etc.)  
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Chapter 7: Conclusions and perspectives 
7.1 Summary 
 
With the advent of systems metabolic engineering, microbes have been engineered for 
synthesizing numerous chemicals and biofuels. However, there are still several roadblocks that 
remain to move microbial cell factories from laboratories to industry. In this thesis, we have 
performed several studies to overcome difficulties associated with development of efficient 
microbial platforms. In our first effort, we built a “Rule of Thumb” model to evaluate the various 
variables that influence microbial performance for the biosynthesis of diverse products under 
different growth conditions. Specifically, the yield of a microbial product remains difficult to 
calculate either by using the reaction stoichiometry or by using the large scale metabolic models.  
Filling this gap has been the focus for Chapter 2 and a statistical model was developed to get 
production yield of chemicals in Saccharomyces Cerevisae.  The developed statistical model 
allows the user to get a priori yield value based on the engineering to be performed.  The model 
can also provide the degree of uncertainty associated with each parameter that can be used to 
improve yield of a product. As a second effort, the use of 13C isotopomer analysis to elucidate 
the intrinsic product yields under complex nutrient conditions and multiple pathways for product 
synthesis has been dischussed in Chapter 3.  Moreover, in the same chapter we have also pointed 
out the value of 13C-MFA in estimating the influence of microbial suboptimal energy metabolism 
on final product yield.    
Besides modeling based studies, metabolic engineering tools were also applied to create 
three microbial platforms. Firstly, to contribute for the efforts in the field of biofuels and at the 
same time to reduce the dependence on food based biofuels, isobutanol synthesis from carbon 
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dioxide was demonstrated by engineering the cyanobacterium Synechocystis 6803.  This research 
work also established the need for process integration along with metabolic engineering to 
improve microbial product titer.  With the minimal engineering required for isobutanol synthesis, 
via co-metabolism of extra carbon substrates, and by using an in situ isobutanol removal system, 
we demonstrated improvements in isobutanol titer from the cyanobacterial platform. In the 
course of this work, isobutanol was found to be degraded photo chemically in the presence of 
hydroxyl radicals.  This discovery necessitates research work for improvements in the reduction 
of radical accumulation during cell cultivation and thereby to reduce product degradation.  With 
a view to offer industrial flexibility in handling carbon feedstock, mixotrophic fermentation was 
performed for isobutanol synthesis by providing the cultures with glucose.  The growth of the 
strain did not increase as expected and the mechanism responsible for this counter action is likely 
due to metabolic imbalance during mixotrophic isobutanol production and it needs further 
investigation to elucidate the proper mechanism. 
Secondly, the decreasing fossil fuel reserves will not only have its negative impact on the 
fuels but also negatively impact the petrochemicals that we use.  PLA has been proposed as a 
substitute for polyethylene but presently its synthesis is food based.  In Chapter 5, we have 
engineered the cyanobacterium Synechocystis 6803 to synthesize D-lactic acid.  We have also 
demonstrated the positive effects of improving cofactor balance on the product titer along with 
improvements in the carbon flux.  In this study, acetate was discovered to improve the 
photoautotropic production of D-lactic acid by about two folds, possibly due to its inhibition of 
pyruvate decarboxylation reaction.  By incorporating various metabolic engineering techniques 
and by feeding a cheap carbon feedstock, this work achieved the highest lactic acid titer ever to 
be reported using cyanobacteria as a host. In addition, this study also guided us in identifying the 
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target pathway (i.e., pyruvate decarboxylation) to improve microbial performance, which may be 
potentially regulated by utilizing synthetic circuits that use either a growth associated or a light 
activated promoter.  
Thirdly, the kinetic models and the isotopomer studies developed in Chapter 6 allowed us 
to compare the metabolic performance of the two strains.  This work enabled us to compare the 
role of nutrients in product synthesis between a low performance and a high performance strain, 
and to identify the rate limiting section of the biosynthesis pathway. Overall this thesis elaborates 
the combined application of isotopomer analysis, modeling and metabolic engineering research 
to improve microbial product yields. 
 
7.2 Challenges with commercialization of industrial biotechnology 
         
           With the need to develop a sustainable technology for resolving environmental concerns, 
replacing fossil fuels and its derivatives, and creating new pharmaceutical chemicals for our 
better living, numerous metabolic engineering works were performed in the past decade.  Despite 
the many successes that were attained in the laboratory, only a handful of them have reached 
commercialization. Listed below are some key reasons for the failure of metabolic engineering 
works to translate into microbial production at industrial scale 149: 
1. Compared to chemical synthesis, both the rate and the yield of microbial biosynthesis are 
very slow.  
2. Substrate pretreatments are costly, reducing the profit margin for chemicals produced 
from microbial cell factories. For example, microbial hosts are still not efficient enough 
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in utilizing the low cost cellulose as their carbon feedstock, while the conversion of 
cellulose into sugars is still commercially challenging. 
3. Product purification is also expensive if the fermentation titers are low.  
4. Contamination associated with bioprocesses can lead to huge loss in product yield, but 
sterilization costs are very high. 
5. Aerobic microbes need oxygen and the energy demand for intensive aeration makes 
bioprocessing very expensive. Moreover, enormous amounts of fresh water are required 
for fermentations. 
6. Engineered strains are often unstable and therefore scaling up is very challenging. 
7. Petroleum is still at an affordable price and therefore the profit margin for microbial 
productions is still very limited. 
     
 
Figure 7.1: Schematic diagram of the various factors that play a major role in the economic 
feasibility of a biofuel production process. 
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In the past decade, several lessons were learnt from the biofuel industry and it cautions us 
that commercialization of biofuel production technology is a difficult task. Thereby, 
industrializing biofuel production would need the combined expertise of biologists, chemists, 
and engineers for its success. In order to reduce the cost of biofuel production, consolidated 
bioprocessing (remove the pretreatment step and integrated fermentation with bio-separation)219 
and co-production of value added products with biofuels are two key approaches in addition to 
metabolic engineering of microbial platforms (Figure 7.1). Moreover, global economy and 
government policy also influence the direction of biofuel industry. Therefore, we believe that 
engineering microbes for producing biofuels or other value-added chemicals is a promising 
direction that would require many years of hard work to realize its true potential. 
 
7.3 Challenges with cyanobacterial bioprocessing 
 
        Metabolic engineering for the synthesis of value added products from cyanobacteria looks 
attractive as they can utilize carbon dioxide and sunlight.  There are two main roadblocks for 
commercializing a technology that synthesizes products from engineered cyanobacteria.  The 
first roadblock is related with cyanobacterial cultivation in large-scale. In large scale, 
cyanobacteria cultures are proposed to be grown either in open ponds or in closed photo-
bioreactors. Although open pond are cheap for operation, they require year round sunlight as 
well as a warm climate, placing a strong limitation on the geographical location. Open ponds 
also have the other disadvantage of water loss by evaporation and a huge risk of microbial 
contamination. On the other hand, closed bioreactors looks like a good alternative, but they are 
still very expensive to operate 220. Algal photo-bioreactors also often suffer from higher 
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maintenance costs due to the formation of bio-films that block light penetrations. The second 
roadblock is associated with the low rates and titers of product synthesis in engineered 
cyanobacteria compared to their heterotrophic cousins. For example, an E. coli strain produced 
5.2 g/L of fatty acids in 3 days 221, whereas the highest fatty acid titer in cyanobacteria was 
below 0.2 g/L after 2-weeks of cultivation 172. Similarly, engineered Synechocystis 6803 
achieved only 0.2 mg/L fatty alcohol, a 3000 fold lower titer as compared to the  levels achieved 
by engineered E. coli (0.6 g/L) 222, 30. Cyanobacterial biosynthesis often takes weeks to 
synthesize a chemical in reasonable titers and this increases the operation along with 
maintenance costs. Long fermentations may also lead to product degradation and microbial 
contamination 136, further reducing the profit margin.  
To overcome the cost due to the low productivity from cyanobacterial biofactories, we 
have proposed the integration of wastewater treatment with bio-production of D-lactate in our 
future research work. We believe that, the natural ability of cyanobacteria in utilizing N and P 
from wastewater along with its potential to synthesize value-added chemical synthesis from CO2 
using sunlight would result in a commercially viable process technology. Besides, strict life-
cycle-analysis needs to be performed to reveal the energy, water and environmental impacts from 
these phototrophic microbial platforms 223.       
7.4  Recent developments in synthetic biology 
 
Development of engineered microbes for artemisinic acid (precursor to the antimalarial 
drug artemisinin) production has been one of the major success stories since the inception of 
metabolic engineering 78.  Towards developing a strain capable of synthesizing artemisinic acid 
at industrial levels 224, it has been quoted that very little time and money were focused on 
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identifying the right metabolic pathways.   The rest of the efforts were focused on applying the 
various synthetic biology tools to iteratively improve the performance of the strain 225.  Synthetic 
biology was utilized to improve the production levels by carefully coordinating the expression of 
multiple genes to reduce intermediates accumulation, by balancing cofactors and by enriching 
precursors.  Thereby, synthetic biology tools along with systems analysis and metabolic 
modeling can significantly speed up pathway optimization and strain development.  
 In recent studies, synthetic biology has extensively been applied for balancing metabolic 
pathways to increase the performance of the engineered microbes 226.  The simplest strategy was 
to engineer cells by employing different promoters of varying strength and this has been 
successful on numerous occasions150, 227, 228. Balancing the expression of all genes in a pathway 
can also be achieved by manipulating at mRNA level.  This can be accomplished by varying the 
stability of specific mRNA segments that code for the enzyme 12, by designing synthetic 
ribosome binding sites 229 and by utilizing transcription factor based approach to reprogram gene 
transcription at  global level 85.  Metabolite channeling to improve product yield has also been 
performed to improve performance by utilizing synthetic protein scaffolds 230, 231.  Moreover, 
dynamic sensor-regulator systems have been developed to overcome toxicity of intermediates by 
switching the pathway at the  correct time and thereby increasing the overall performance 110.  
Finally, high throughput genome engineering are being developed to speed up the creation of 
optimal hosts. For example, multiplexed automated genome engineering (MAGE), a strategy for 
large scale reprogramming of the genome based on natural selection principles may accelerate 
metabolic engineering by effectively tuning the expression of multiple genes 232. In addition, 
trackable multiplex recombineering (TRMR) can create and evaluate thousands of genetic 
modifications simultaneously 233. 
128 
 
 
  
7.5 Future directions 
  
Overall, there are still many challenges associated with developing industrial-strength strains for 
the synthesis of chemicals.  However, several opportunities do exist to make microbial processes 
to be competitive with chemical synthesis. Along with developing more powerful synthetic 
biology tools, research must also focus on developing cost effective technologies to overcome 
challenges mentioned in Chapter 7.2.  Thereby, microbial cell factories should be engineered to 
metabolize multiple substrates, synthesize multiple products, reduce byproducts, and to minimize 
oxygen demand as well as to engineer them with control systems to uptake key precursors and 
synthesize products as needed.  All these engineering must be performed in an integrated manner 
with a systems level understanding of the cell at all levels (Figure 7.2).  Systems level analysis 
will enable researchers to identify bottleneck pathways and genes that can be targeted for 
improved performance. Model development to simulate the output of synthetic biology tools 
would enable us to predict and understand the dynamics of engineered pathways.  This 
development would lead to a tremendous reduction in experimental hours by screening for 
optimal pathway designs on a computer, before engineering it into a host cell. Also, to improve 
the economical margin of cyanobacterial based product synthesis, the engineered algal process 
can be integrated with a wastewater treatment facility. On the other hand, our incomplete 
knowledge about the biology of the cell often requires guesses to perform metabolic engineering.  
As our understanding about the cell grows, guesswork based experiments would be avoided 
leading to more successful outcomes.  Simultaneously, we have to work with process engineers 
to bridge gaps between laboratories studies and industrial applications. With all these 
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developments, it is possible that in the near future, we may realize the dream of using microbial 
cell factories for the production of diverse value-added chemicals at industrial scale from 
cheaper feedstock. 
 
Figure 7.2: Schematic diagram of an integrated iterative approach required for the development 
of high-performance microbial strains towards industrial commercialization. 
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Appendix 1: Microbial metabolisms and cell culture models 
for biofuel production. Bioenergy: Principles and 
Applications. 
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Appendix 2: Engineering Escherichia coli to convert acetic 
acid to free fatty acids. 
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Appendix 3: Evaluating factors that influence microbial 
synthesis yields by regression with numerical and categorical 
variables. 
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